Protein Interactions at Endothelial Junctions and Signaling Mechanisms Regulating Endothelial Permeability

Circulation Research

Volumn 120, Issue 1, 2017, Pages 179-206

  Komarova, Yulia A ^a   Kruse, Kevin ^a   Mehta, Dolly ^a   Malik, Asrar B ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

adherens junctions; blood cells; endothelial cells; lung diseases; signal transduction

Indexed keywords

ACYLTRANSFERASE; GROWTH FACTOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MICRORNA; NITRIC OXIDE SYNTHASE; PROTEIN CDC42; PROTEIN TYROSINE PHOSPHATASE; RAC1 PROTEIN; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; RHO KINASE INHIBITOR; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; TIGHT JUNCTION PROTEIN; TRANSIENT RECEPTOR POTENTIAL CHANNEL; TRANSIENT RECEPTOR POTENTIAL CHANNEL M2; VANILLOID RECEPTOR; VASCULAR ENDOTHELIAL CADHERIN; PROTEIN BINDING;

ACTIN FILAMENT; ADHERENS JUNCTION; CARDIOVASCULAR DISEASE; CELL THERAPY; ENDOTHELIUM; GAP JUNCTION; INTRACELLULAR SIGNALING; LUNG DISEASE; NONHUMAN; PERMEABILITY; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN PROCESSING; REVIEW; TIGHT JUNCTION; VASCULITIS; ANIMAL; CAPILLARY PERMEABILITY; ENDOTHELIUM CELL; HUMAN; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM;

ADHERENS JUNCTIONS; ANIMALS; CAPILLARY PERMEABILITY; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; GAP JUNCTIONS; HUMANS; PROTEIN BINDING; SIGNAL TRANSDUCTION;

EID: 85009104892     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.116.306534     Document Type: Review

References (416)

1. Pappenheimer JR, Renkin EM, Borrero LM. Filtration, diffusion and molecular sieving through peripheral capillary membranes; a contribution to the pore theory of capillary permeability. Am J Physiol. 1951;167:13-46.
2. Del Vecchio PJ, Sifinger-Birnboim A, Shepard JM, Bizios R, Cooper JA, Malik AB. Endothelial monolayer permeability to macromolecules. Federation Proc 1987;46:2511-2515
3. Sifinger-Birnboim A, Del Vecchio PJ, Cooper JA, Blumenstock FA, Shepard JM, Malik AB. Molecular sieving characteristics of the cultured endothelial monolayer. J Cell Physiol. 1987;132:111-117. doi: 10.1002/ jcp.1041320115.
4. Schneeberger EE. Circulating proteins and macromolecular transport across continuous, nonfenestrated endothelium. Ann N Y Acad Sci. 1982;401:25-37.
5. Weisberg HF. Osmotic pressure of the serum proteins. Ann Clin Lab Sci. 1978;8:155-164.
6. Xie Z, Ghosh CC, Patel R, Iwaki S, Gaskins D, Nelson C, Jones N, Greipp PR, Parikh SM, Druey KM. Vascular endothelial hyperperme-ability induces the clinical symptoms of Clarkson disease (the systemic capillary leak syndrome). Blood. 2012;119:4321-4332. doi: 10.1182/ blood-2011-08-375816.
7. Bouillet L, Mannic T, Arboleas M, Subileau M, Massot C, Drouet C, Huber P, Vilgrain I. Hereditary angioedema: key role for kallikrein and bradykinin in vascular endothelial-cadherin cleavage and edema formation. J Allergy Clin Immunol. 2011;128:232-234. doi: 10.1016/j. jaci.2011.02.017.
8. Kaplan AP. Clinical practice. Chronic urticaria and angioedema. N Engl J Med. 2002;346:175-179. doi: 10.1056/NEJMcp011186.
9. Herwig MC, Tsokos M, Hermanns MI, Kirkpatrick CJ, Müller AM. Vascular endothelial cadherin expression in lung specimens of patients with sepsis-induced acute respiratory distress syndrome and endothelial cell cultures. Pathobiology. 2013;80:245-251. doi: 10.1159/000347062.
10. Lee WL, Slutsky AS. Sepsis and endothelial permeability. N Engl J Med. 2010;363:689-691. doi: 10.1056/NEJMcibr1007320.
11. Klaassen I, Van Noorden CJ, Schlingemann RO. Molecular basis of the inner blood-retinal barrier and its breakdown in diabetic macular edema and other pathological conditions. Prog Retin Eye Res. 2013;34:19-48. doi: 10.1016/j.preteyeres.2013.02.001.
12. Cheung N, Tikellis G, Wang JJ. Diabetic retinopathy. Ophthalmology. 2007;114:2098-9; author reply 2099. doi: 10.1016/j.ophtha.2007.07.010.
13. Aroca PR, Salvat M, Fernández J, Méndez I. Risk factors for diffuse and focal macular edema. J Diabetes Complications. 2004;18:211-215. doi: 10.1016/S1056-8727(03)00038-2.
14. Zlokovic BV. Remodeling after stroke. Nat Med. 2006;12:390-391. doi: 10.1038/nm0406-390.
15. Iłzecka J. The structure and function of blood-brain barrier in isch-aemic brain stroke process. Ann Univ Mariae Curie Sklodowska Med. 1996;51:123-127.
16. Iłzecka J, Mitosek-Szewczyk K. Cerebral strokes immunopathology. Ann Univ Mariae Curie Sklodowska Med. 1996;51:103-107.
17. Morganti-Kossmann MC, Rancan M, Stahel PF, Kossmann T. Infammatory response in acute traumatic brain injury: a double-edged sword. Curr Opin Crit Care. 2002;8:101-105.
18. Reese TS, Karnovsky MJ. Fine structural localization of a blood-brain barrier to exogenous peroxidase. J Cell Biol. 1967;34:207-217.
19. Simionescu M, Simionescu N, Palade GE. Segmental differentiations of cell junctions in the vascular endothelium. The microvasculature. J Cell Biol. 1975;67:863-885.
20. Hüttner I, Boutet M, More RH. Gap junctions in arterial endothelium. J Cell Biol. 1973;57:247-252.
21. Firth JA, Bauman KF, Sibley CP. The intercellular junctions of guinea-pig placental capillaries: a possible structural basis for endothelial solute permeability. J Ultrastruct Res. 1983;85:45-57.
22. Qu Y, Dahl G. Accessibility of cx46 hemichannels for uncharged molecules and its modulation by voltage. Biophys J. 2004;86:1502-1509. doi: 10.1016/S0006-3495(04)74218-6.
23. Hoh JH, Sosinsky GE, Revel JP, Hansma PK. Structure of the extracellular surface of the gap junction by atomic force microscopy. Biophys J. 1993;65:149-163. doi: 10.1016/S0006-3495(93)81074-9.
24. Das Sarma J, Meyer RA, Wang F, Abraham V, Lo CW, Koval M. Multimeric connexin interactions prior to the trans-Golgi network. J Cell Sci. 2001;114:4013-4024.
25. Vanslyke JK, Naus CC, Musil LS. Conformational maturation and post-ER multisubunit assembly of gap junction proteins. Mol Biol Cell. 2009;20:2451-2463. doi: 10.1091/mbc.E09-01-0062.
26. Smith TD, Mohankumar A, Minogue PJ, Beyer EC, Berthoud VM, Koval M. Cytoplasmic amino acids within the membrane interface region infu-ence connexin oligomerization. J Membr Biol. 2012;245:221-230. doi: 10.1007/s00232-012-9443-5.
27. Barrio LC, Suchyna T, Bargiello T, Xu LX, Roginski RS, Bennett MV, Nicholson BJ. Gap junctions formed by connexins 26 and 32 alone and in combination are differently affected by applied voltage. Proc Natl Acad Sci U S A. 1991;88:8410-8414.
28. Valiunas V, Gemel J, Brink PR, Beyer EC. Gap junction channels formed by coexpressed connexin40 and connexin43. Am J Physiol Heart Circ Physiol. 2001;281:H1675-H1689.
29. Beyer EC, Gemel J, Martínez A, Berthoud VM, Valiunas V, Moreno AP, Brink PR. Heteromeric mixing of connexins: compatibility of partners and functional consequences. Cell Commun Adhes. 2001;8:199-204.
30. Cottrell GT, Burt JM. Heterotypic gap junction channel formation between heteromeric and homomeric Cx40 and Cx43 connexons. Am J Physiol Cell Physiol. 2001;281:C1559-C1567.
31. Johnson TL, Nerem RM. Endothelial connexin 37, connexin 40, and con-nexin 43 respond uniquely to substrate and shear stress. Endothelium. 2007;14:215-226. doi: 10.1080/10623320701617233.
32. Hakim CH, Jackson WF, Segal SS. Connexin isoform expression in smooth muscle cells and endothelial cells of hamster cheek pouch arteri-oles and retractor feed arteries. Microcirculation. 2008;15:503-514. doi: 10.1080/10739680801982808.
33. Looft-Wilson RC, Payne GW, Segal SS. Connexin expression and conducted vasodilation along arteriolar endothelium in mouse skeletal muscle. J Appl Physiol (1985). 2004;97:1152-1158. doi: 10.1152/ japplphysiol.00133.2004.
34. Dora KA, Xia J, Duling BR. Endothelial cell signaling during conducted vasomotor responses. Am J Physiol Heart Circ Physiol. 2003;285:H119- H126. doi: 10.1152/ajpheart.00643.2002.
35. Liao Y, Day KH, Damon DN, Duling BR. Endothelial cell-specifc knockout of connexin 43 causes hypotension and bradycardia in mice. Proc Natl Acad Sci U S A. 2001;98:9989-9994. doi: 10.1073/pnas.171305298.
36. Krattinger N, Capponi A, Mazzolai L, Aubert JF, Caille D, Nicod P, Waeber G, Meda P, Haefiger JA. Connexin40 regulates renin production and blood pressure. Kidney Int. 2007;72:814-822. doi: 10.1038/ sj.ki.5002423.
37. Wagner C, de Wit C, Gerl M, Kurtz A, Höcherl K. Increased expression of cyclooxygenase 2 contributes to aberrant renin production in con-nexin 40-defcient kidneys. Am J Physiol Regul Integr Comp Physiol. 2007;293:R1781-R1786. doi: 10.1152/ajpregu.00439.2007.
38. Wagner C, de Wit C, Kurtz L, Grünberger C, Kurtz A, Schweda F. Connexin40 is essential for the pressure control of renin synthesis and secretion. Circ Res. 2007;100:556-563. doi: 10.1161/01. RES.0000258856.19922.45.
39. Parthasarathi K, Ichimura H, Monma E, Lindert J, Quadri S, Issekutz A, Bhattacharya J. Connexin 43 mediates spread of Ca2+-dependent proin-fammatory responses in lung capillaries. J Clin Invest. 2006;116:2193-2200. doi: 10.1172/JCI26605.
40. Simionescu M, Simionescu N, Palade GE. Segmental differentiations of cell junctions in the vascular endothelium. Arteries and veins. J Cell Biol. 1976;68:705-723.
41. Schneeberger EE. Structure of intercellular junctions in different segments of the intrapulmonary vasculature. Ann N Y Acad Sci. 1982;384:54-63.
42. Baluk P, Fuxe J, Hashizume H, Romano T, Lashnits E, Butz S, Vestweber D, Corada M, Molendini C, Dejana E, McDonald DM. Functionally specialized junctions between endothelial cells of lymphatic vessels. J Exp Med. 2007;204:2349-2362. doi: 10.1084/jem.20062596.
43. Liebner S, Gerhardt H, Wolburg H. Differential expression of endothelial be-ta-catenin and plakoglobin during development and maturation of the blood-brain and blood-retina barrier in the chicken. Dev Dyn. 2000;217:86-98. doi: 10.1002/(SICI)1097-0177(200001)217:1<86::AID-DVDY8>3.0.CO;2-E.
44. Liebner S, Kniesel U, Kalbacher H, Wolburg H. Correlation of tight junction morphology with the expression of tight junction proteins in blood-brain barrier endothelial cells. Eur J Cell Biol. 2000;79:707-717. doi: 10.1078/0171-9335-00101.
45. Lippoldt A, Liebner S, Andbjer B, Kalbacher H, Wolburg H, Haller H, Fuxe K. Organization of choroid plexus epithelial and endothelial cell tight junctions and regulation of claudin-1, -2 and -5 expression by protein kinase C. Neuroreport. 2000;11:1427-1431.
46. Rascher G, Wolburg H. The tight junctions of the leptomeningeal blood-cerebrospinal fuid barrier during development. J Hirnforsch. 1997;38:525-540.
47. Wolburg H, Lippoldt A. Tight junctions of the blood-brain barrier: development, composition and regulation. Vascul Pharmacol. 2002;38:323-337.
48. Luo Y, Xiao W, Zhu X, Mao Y, Liu X, Chen X, Huang J, Tang S, Rizzolo LJ. Differential expression of claudins in retinas during normal development and the angiogenesis of oxygen-induced retinopathy. Invest Ophthalmol Vis Sci. 2011;52:7556-7564. doi: 10.1167/iovs.11-7185.
49. Petito CK, Pulsinelli WA, Jacobson G, Plum F. Edema and vascular permeability in cerebral ischemia: comparison between ischemic neuronal damage and infarction. J Neuropathol Exp Neurol. 1982;41:423-436.
50. Bralet AM, Beley A, Beley P, Bralet J. Brain edema and blood-brain barrier permeability following quantitative cerebral microembolism. Stroke. 1979;10:34-38.
51. Yang Y, Estrada EY, Thompson JF, Liu W, Rosenberg GA. Matrix me-talloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat. J Cereb Blood Flow Metab. 2007;27:697-709. doi: 10.1038/sj.jcbfm.9600375.
52. Furuse M, Hirase T, Itoh M, Nagafuchi A, Yonemura S, Tsukita S, Tsukita S. Occludin: a novel integral membrane protein localizing at tight junctions. J Cell Biol. 1993;123:1777-1788.
53. Hirase T, Staddon JM, Saitou M, Ando-Akatsuka Y, Itoh M, Furuse M, Fujimoto K, Tsukita S, Rubin LL. Occludin as a possible determinant of tight junction permeability in endothelial cells. J Cell Sci. 1997;110 (Pt 14):1603-1613.
54. Furuse M, Fujita K, Hiiragi T, Fujimoto K, Tsukita S. Claudin-1 and -2: novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin. J Cell Biol. 1998;141:1539-1550.
55. Furuse M, Sasaki H, Fujimoto K, Tsukita S. A single gene product, clau-din-1 or -2, reconstitutes tight junction strands and recruits occludin in fbroblasts. J Cell Biol. 1998;143:391-401.
56. Martìn-Padura I, Lostaglio S, Schneemann M, Williams L, Romano M, Fruscella P, Panzeri C, Stoppacciaro A, Ruco L, Villa A, Simmons D, Dejana E. Junctional adhesion molecule, a novel member of the immuno-globulin superfamily that distributes at intercellular junctions and modulates monocyte transmigration. J Cell Biol. 1998;142:117-127.
57. Yamazaki Y, Okawa K, Yano T, Tsukita S, Tsukita S. Optimized proteomic analysis on gels of cell-cell adhering junctional membrane proteins. Biochemistry. 2008;47:5378-5386. doi: 10.1021/bi8002567.
58. Schneeberger EE, Lynch RD. The tight junction: a multifunctional complex. Am J Physiol Cell Physiol. 2004;286:C1213-C1228. doi: 10.1152/ ajpcell.00558.2003.
59. Nitta T, Hata M, Gotoh S, Seo Y, Sasaki H, Hashimoto N, Furuse M, Tsukita S. Size-selective loosening of the blood-brain barrier in clau-din-5-defcient mice. J Cell Biol. 2003;161:653-660. doi: 10.1083/ jcb.200302070.
60. Wolburg H, Wolburg-Buchholz K, Kraus J, Rascher-Eggstein G, Liebner S, Hamm S, Duffner F, Grote EH, Risau W, Engelhardt B. Localization of claudin-3 in tight junctions of the blood-brain barrier is selectively lost during experimental autoimmune encephalomyelitis and human glioblas-toma multiforme. Acta Neuropathol. 2003;105:586-592. doi: 10.1007/ s00401-003-0688-z.
61. Liebner S, Fischmann A, Rascher G, Duffner F, Grote EH, Kalbacher H, Wolburg H. Claudin-1 and claudin-5 expression and tight junction morphology are altered in blood vessels of human glioblastoma multiforme. Acta Neuropathol. 2000;100:323-331.
62. Itoh M, Furuse M, Morita K, Kubota K, Saitou M, Tsukita S. Direct binding of three tight junction-associated MAGUKs, ZO-1, ZO-2, and ZO-3, with the COOH termini of claudins. J Cell Biol. 1999;147:1351-1363.
63. Itoh M, Morita K, Tsukita S. Characterization of ZO-2 as a MAGUK family member associated with tight as well as adherens junctions with a binding affnity to occludin and alpha catenin. J Biol Chem. 1999;274:5981-5986.
64. Brooks TA, Hawkins BT, Huber JD, Egleton RD, Davis TP. Chronic infammatory pain leads to increased blood-brain barrier permeability and tight junction protein alterations. Am J Physiol Heart Circ Physiol. 2005;289:H738-H743. doi: 10.1152/ajpheart.01288.2004.
65. Zlokovic BV, Deane R, Sallstrom J, Chow N, Miano JM. Neurovascular pathways and Alzheimer amyloid beta-peptide. Brain Pathol. 2005;15:78-83.
66. Hawkins BT, Davis TP. The blood-brain barrier/neurovascular unit in health and disease. Pharmacol Rev. 2005;57:173-185. doi: 10.1124/ pr.57.2.4.
67. Saitou M, Furuse M, Sasaki H, Schulzke JD, Fromm M, Takano H, Noda T, Tsukita S. Complex phenotype of mice lacking occludin, a component of tight junction strands. Mol Biol Cell. 2000;11:4131-4142.
68. Barber AJ, Antonetti DA, Gardner TW. Altered expression of retinal occludin and glial fibrillary acidic protein in experimental diabetes. The Penn State Retina Research Group. Invest Ophthalmol Vis Sci. 2000;41:3561-3568.
69. Jain S, Suzuki T, Seth A, Samak G, Rao R. Protein kinase Cζ phos-phorylates occludin and promotes assembly of epithelial tight junctions. Biochem J. 2011;437:289-299. doi: 10.1042/BJ20110587.
70. Xia L, Wang H, Munk S, Kwan J, Goldberg HJ, Fantus IG, Whiteside CI. High glucose activates PKC-zeta and NADPH oxidase through auto-crine TGF-beta1 signaling in mesangial cells. Am J Physiol Renal Physiol. 2008;295:F1705-F1714. doi: 10.1152/ajprenal.00043.2008.
71. Aveleira CA, Lin CM, Abcouwer SF, Ambrosio AF, Antonetti DA. Tnf-alpha signals through pkczeta/nf-kappab to alter the tight junction complex and increase retinal endothelial cell permeability. Diabetes. 2010;59:2872-2882
72. Katsuno T, Umeda K, Matsui T, Hata M, Tamura A, Itoh M, Takeuchi K, Fujimori T, Nabeshima Y, Noda T, Tsukita S, Tsukita S. Defciency of zonula occludens-1 causes embryonic lethal phenotype associated with defected yolk sac angiogenesis and apoptosis of embryonic cells. Mol Biol Cell. 2008;19:2465-2475. doi: 10.1091/mbc.E07-12-1215.
73. Tornavaca O, Chia M, Dufton N, Almagro LO, Conway DE, Randi AM, Schwartz MA, Matter K, Balda MS. ZO-1 controls endothelial adherens junctions, cell-cell tension, angiogenesis, and barrier formation. J Cell Biol. 2015;208:821-838. doi: 10.1083/jcb.201404140.
74. Kirk J, Plumb J, Mirakhur M, McQuaid S. Tight junctional abnormality in multiple sclerosis white matter affects all calibres of vessel and is associated with blood-brain barrier leakage and active demyelination. J Pathol. 2003;201:319-327. doi: 10.1002/path.1434.
75. Hawkins BT, Lundeen TF, Norwood KM, Brooks HL, Egleton RD. Increased blood-brain barrier permeability and altered tight junctions in experimental diabetes in the rat: contribution of hyperglycaemia and matrix metalloproteinases. Diabetologia. 2007;50:202-211. doi: 10.1007/ s00125-006-0485-z.
76. Hawkins BT, Ocheltree SM, Norwood KM, Egleton RD. Decreased blood-brain barrier permeability to fuorescein in streptozotocin-treated rats. Neurosci Lett. 2007;411:1-5. doi: 10.1016/j.neulet.2006.09.010.
77. Tran KA, Zhang X, Predescu D, Huang X, Machado RF, Göthert JR, Malik AB, Valyi-Nagy T, Zhao YY. Endothelial β-Catenin Signaling Is Required for Maintaining Adult Blood-Brain Barrier Integrity and Central Nervous System Homeostasis. Circulation. 2016;133:177-186. doi: 10.1161/CIRCULATIONAHA.115.015982.
78. Liebner S, Corada M, Bangsow T, Babbage J, Taddei A, Czupalla CJ, Reis M, Felici A, Wolburg H, Fruttiger M, Taketo MM, von Melchner H, Plate KH, Gerhardt H, Dejana E. Wnt/beta-catenin signaling controls development of the blood-brain barrier. J Cell Biol. 2008;183:409-417. doi: 10.1083/jcb.200806024.
79. Leach L, Clark P, Lampugnani MG, Arroyo AG, Dejana E, Firth JA. Immunoelectron characterisation of the inter-endothelial junctions of human term placenta. J Cell Sci. 1993;104(pt 4):1073-1081.
80. Tamura K, Shan WS, Hendrickson WA, Colman DR, Shapiro L. Structure-function analysis of cell adhesion by neural (N-) cadherin. Neuron. 1998;20:1153-1163.
81. Lampugnani MG, Corada M, Caveda L, Breviario F, Ayalon O, Geiger B, Dejana E. The molecular organization of endothelial cell to cell junctions: differential association of plakoglobin, beta-catenin, and alpha-catenin with vascular endothelial cadherin (VE-cadherin). J Cell Biol. 1995;129:203-217.
82. Breier G, Breviario F, Caveda L, Berthier R, Schnürch H, Gotsch U, Vestweber D, Risau W, Dejana E. Molecular cloning and expression of murine vascular endothelial-cadherin in early stage development of cardiovascular system. Blood. 1996;87:630-641.
83. Taddei A, Giampietro C, Conti A, Orsenigo F, Breviario F, Pirazzoli V, Potente M, Daly C, Dimmeler S, Dejana E. Endothelial adherens junctions control tight junctions by VE-cadherin-mediated upregulation of claudin-5. Nat Cell Biol. 2008;10:923-934. doi: 10.1038/ncb1752.
84. Corada M, Liao F, Lindgren M, Lampugnani MG, Breviario F, Frank R, Muller WA, Hicklin DJ, Bohlen P, Dejana E. Monoclonal antibodies directed to different regions of vascular endothelial cadherin extracellular domain affect adhesion and clustering of the protein and modulate endo-thelial permeability. Blood. 2001;97:1679-1684.
85. Crosby CV, Fleming PA, Argraves WS, Corada M, Zanetta L, Dejana E, Drake CJ. VE-cadherin is not required for the formation of nascent blood vessels but acts to prevent their disassembly. Blood. 2005;105:2771-2776. doi: 10.1182/blood-2004-06-2244.
86. Vittet D, Buchou T, Schweitzer A, Dejana E, Huber P. Targeted null-mutation in the vascular endothelial-cadherin gene impairs the organization of vascular-like structures in embryoid bodies. Proc Natl Acad Sci U S A. 1997;94:6273-6278.
87. Frye M, Dierkes M, Küppers V, Vockel M, Tomm J, Zeuschner D, Rossaint J, Zarbock A, Koh G Y, Peters K, Nottebaum AF, Vestweber D. Interfering with VE-PTP stabilizes endothelial junctions in vivo via Tie-2 in the absence of VE-cadherin. J Exp Med. 2015;212:2267-2287. doi: 10.1084/jem.20150718.
88. Liaw CW, Cannon C, Power MD, Kiboneka PK, Rubin LL. Identification and cloning of two species of cadherins in bovine endothelial cells. EMBO J. 1990;9:2701-2708.
89. Salomon D, Ayalon O, Patel-King R, Hynes RO, Geiger B. Extrajunctional distribution of N-cadherin in cultured human endothelial cells. J Cell Sci. 1992;102(pt 1):7-17.
90. Gerhardt H, Liebner S, Redies C, Wolburg H. N-cadherin expression in endothelial cells during early angiogenesis in the eye and brain of the chicken: relation to blood-retina and blood-brain barrier development. Eur J Neurosci. 1999;11:1191-1201.
91. Gerhardt H, Wolburg H, Redies C. N-cadherin mediates pericytic-endothelial interaction during brain angiogenesis in the chicken. Dev Dyn. 2000;218:472-479. doi: 10.1002/1097-0177(200007)218:3<472:: AID-DVDY1008>3.0.CO;2-#.
92. Tillet E, Vittet D, Féraud O, Moore R, Kemler R, Huber P. N-cadherin defciency impairs pericyte recruitment, and not endothelial differentiation or sprouting, in embryonic stem cell-derived angiogenesis. Exp Cell Res. 2005;310:392-400. doi: 10.1016/j.yexcr.2005.08.021.
93. Navarro P, Ruco L, Dejana E. Differential localization of VE- and N-cadherins in human endothelial cells: VE-cadherin competes with N-cadherin for junctional localization. J Cell Biol. 1998;140:1475-1484.
94. Gentil-dit-Maurin A, Oun S, Almagro S, Bouillot S, Courçon M, Linnepe R, Vestweber D, Huber P, Tillet E. Unraveling the distinct distributions of VE- and N-cadherins in endothelial cells: a key role for p120-catenin. Exp Cell Res. 2010;316:2587-2599. doi: 10.1016/j. yexcr.2010.06.015.
95. Luo Y, Radice GL. N-cadherin acts upstream of VE-cadherin in controlling vascular morphogenesis. J Cell Biol. 2005;169:29-34. doi: 10.1083/ jcb.200411127.
96. Lindahl P, Johansson BR, Levéen P, Betsholtz C. Pericyte loss and microaneurysm formation in PDGF-B-defcient mice. Science. 1997;277:242-245.
97. Armulik A, Genové G, Mäe M, Nisancioglu MH, Wallgard E, Niaudet C, He L, Norlin J, Lindblom P, Strittmatter K, Johansson BR, Betsholtz C. Pericytes regulate the blood-brain barrier. Nature. 2010;468:557-561. doi: 10.1038/nature09522.
98. Daneman R, Zhou L, Kebede AA, Barres BA. Pericytes are required for blood-brain barrier integrity during embryogenesis. Nature. 2010;468:562-566. doi: 10.1038/nature09513.
99. Sagare AP, Bell RD, Zhao Z, Ma Q, Winkler EA, Ramanathan A, Zlokovic BV. Pericyte loss infuences Alzheimer-like neurodegeneration in mice. Nat Commun. 2013;4:2932. doi: 10.1038/ncomms3932.
100. Wang YL, Hui YN, Guo B, Ma JX. Strengthening tight junctions of retinal microvascular endothelial cells by pericytes under normoxia and hypoxia involving angiopoietin-1 signal way. Eye (Lond). 2007;21:1501-1510. doi: 10.1038/sj.eye.6702716.
101. Kim JH, Kim JH, Yu YS, Kim DH, Kim KW. Recruitment of pericytes and astrocytes is closely related to the formation of tight junction in developing retinal vessels. J Neurosci Res. 2009;87:653-659. doi: 10.1002/ jnr.21884.
102. Hellström M, Gerhardt H, Kalén M, Li X, Eriksson U, Wolburg H, Betsholtz C. Lack of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesis. J Cell Biol. 2001;153:543-553.
103. Jian MY, Liu Y, Li Q, Wolkowicz P, Alexeyev M, Zmijewski J, Creighton J. N-cadherin coordinates AMP kinase-mediated lung vascular repair. Am J Physiol Lung Cell Mol Physiol. 2016;310:L71-L85. doi: 10.1152/ ajplung.00227.2015.
104. Ivanov D, Philippova M, Antropova J, Gubaeva F, Iljinskaya O, Tararak E, Bochkov V, Erne P, Resink T, Tkachuk V. Expression of cell adhesion molecule T-cadherin in the human vasculature. Histochem Cell Biol. 2001;115:231-242.
105. Dames SA, Bang E, Haüssinger D, Ahrens T, Engel J, Grzesiek S. Insights into the low adhesive capacity of human T-cadherin from the NMR structure of Its N-terminal extracellular domain. J Biol Chem. 2008;283:23485-23495. doi: 10.1074/jbc.M708335200.
106. Ivanov D, Philippova M, Tkachuk V, Erne P, Resink T. Cell adhesion molecule T-cadherin regulates vascular cell adhesion, phenotype and mo-tility. Exp Cell Res. 2004;293:207-218.
107. Philippova M, Banf A, Ivanov D, Gianni-Barrera R, Allenspach R, Erne P, Resink T. Atypical GPI-anchored T-cadherin stimulates angiogenesis in vitro and in vivo. Arterioscler Thromb Vasc Biol. 2006;26:2222-2230. doi: 10.1161/01.ATV.0000238356.20565.92.
108. Andreeva AV, Han J, Kutuzov MA, Profrovic J, Tkachuk VA , Voyno-Yasenetskaya TA. T-cadherin modulates endothelial barrier function. J Cell Physiol. 2010;223:94-102. doi: 10.1002/jcp.22014.
109. Dorrell MI, Aguilar E, Friedlander M. Retinal vascular development is mediated by endothelial flopodia, a preexisting astrocytic template and specifc R-cadherin adhesion. Invest Ophthalmol Vis Sci. 2002;43:3500-3510.
110. Shan WS, Tanaka H, Phillips GR, Arndt K, Yoshida M, Colman DR, Shapiro L. Functional cis-heterodimers of N- and R-cadherins. J Cell Biol. 2000;148:579-590.
111. Rampon C, Prandini MH, Bouillot S, Pointu H, Tillet E, Frank R, Vernet M, Huber P. Protocadherin 12 (VE-cadherin 2) is expressed in endotheli-al, trophoblast, and mesangial cells. Exp Cell Res. 2005;302:48-60. doi: 10.1016/j.yexcr.2004.08.024.
112. Telo' P, Breviario F, Huber P, Panzeri C, Dejana E. Identification of a novel cadherin (vascular endothelial cadherin-2) located at intercellular junctions in endothelial cells. J Biol Chem. 1998;273:17565-17572.
113. Philibert C, Bouillot S, Huber P, Faury G. Protocadherin-12 def-ciency leads to modifcations in the structure and function of arteries in mice. Pathol Biol (Paris). 2012;60:34-40. doi: 10.1016/j. patbio.2011.11.005.
114. Shapiro L, Fannon AM, Kwong PD, Thompson A, Lehmann MS, Grübel G, Legrand JF, Als-Nielsen J, Colman DR, Hendrickson WA. Structural basis of cell-cell adhesion by cadherins. Nature. 1995;374:327-337. doi: 10.1038/374327a0.
115. Brasch J, Harrison OJ, Ahlsen G, Carnally SM, Henderson RM, Honig B, Shapiro L. Structure and binding mechanism of vascular endothelial cadherin: a divergent classical cadherin. J Mol Biol. 2011;408:57-73. doi: 10.1016/j.jmb.2011.01.031.
116. Harrison OJ, Jin X, Hong S, et al. The extracellular architecture of adher-ens junctions revealed by crystal structures of type I cadherins. Structure. 2011;19:244-256. doi: 10.1016/j.str.2010.11.016.
117. Wu Y, Jin X, Harrison O, Shapiro L, Honig BH, Ben-Shaul A. Cooperativity between trans and cis interactions in cadherin-mediated junction formation. Proc Natl Acad Sci U S A. 2010;107:17592-17597. doi: 10.1073/pnas.1011247107.
118. Patel SD, Ciatto C, Chen CP, Bahna F, Rajebhosale M, Arkus N, Schieren I, Jessell TM, Honig B, Price SR, Shapiro L. Type II cadherin ectodo-main structures: implications for classical cadherin specifcity. Cell. 2006;124:1255-1268. doi: 10.1016/j.cell.2005.12.046.
119. Zhang Y, Sivasankar S, Nelson WJ, Chu S. Resolving cadherin interactions and binding cooperativity at the single-molecule level. Proc Natl Acad Sci U S A. 2009;106:109-114. doi: 10.1073/pnas.0811350106.
120. n control blood pressure by mediating endothelial mechanotransduction. J Clin Invest. 2015;125:3077-3086. doi: 10.1172/JCI81067.
121. Nelson CM, Chen CS. VE-cadherin simultaneously stimulates and inhibits cell proliferation by altering cytoskeletal structure and tension. J Cell Sci. 2003;116:3571-3581. doi: 10.1242/jcs.00680.
122. Nelson CM, Pirone DM, Tan JL, Chen CS. Vascular endothelial-cad-herin regulates cytoskeletal tension, cell spreading, and focal adhesions by stimulating RhoA. Mol Biol Cell. 2004;15:2943-2953. doi: 10.1091/ mbc.E03-10-0745.
123. Huveneers S, Oldenburg J, Spanjaard E, van der Krogt G, Grigoriev I, Akhmanova A, Rehmann H, de Rooij J. Vinculin associates with endothelial VE-cadherin junctions to control force-dependent remodeling. J Cell Biol. 2012;196:641-652. doi: 10.1083/jcb.201108120.
124. Hong S, Troyanovsky RB, Troyanovsky SM. Binding to F-actin guides cadherin cluster assembly, stability, and movement. J Cell Biol. 2013;201:131-143. doi: 10.1083/jcb.201211054.
125. Barry AK, Wang N, Leckband DE. Local VE-cadherin mechanotransduction triggers long-ranged remodeling of endothelial monolayers. J Cell Sci. 2015;128:1341-1351. doi: 10.1242/jcs.159954.
126. Liu Z, Tan JL, Cohen DM, Yang MT, Sniadecki NJ, Ruiz SA, Nelson CM, Chen CS. Mechanical tugging force regulates the size of cell-cell junctions. Proc Natl Acad Sci U S A. 2010;107:9944-9949. doi: 10.1073/ pnas.0914547107.
127. Rimm DL, Koslov ER, Kebriaei P, Cianci CD, Morrow JS. Alpha 1(E)-catenin is an actin-binding and -bundling protein mediating the attachment of F-actin to the membrane adhesion complex. Proc Natl Acad Sci U S A. 1995;92:8813-8817.
128. Yao M, Qiu W, Liu R, Efremov AK, Cong P, Seddiki R, Payre M, Lim CT, Ladoux B, Mège RM, Yan J. Force-dependent conformational switch of a-catenin controls vinculin binding. Nat Commun. 2014;5:4525. doi: 10.1038/ncomms5525.
129. Buckley CD, Tan J, Anderson KL, Hanein D, Volkmann N, Weis WI, Nelson WJ, Dunn AR. Cell adhesion. The minimal cadherin-catenin complex binds to actin flaments under force. Science. 2014;346:1254211. doi: 10.1126/science.1254211.
130. Drees F, Pokutta S, Yamada S, Nelson WJ, Weis WI. Alpha-catenin is a molecular switch that binds E-cadherin-beta-catenin and regulates actin-flament assembly. Cell. 2005;123:903-915. doi: 10.1016/j. cell.2005.09.021.
131. Huveneers S, de Rooij J. Mechanosensitive systems at the cadherin-F-actin interface. J Cell Sci. 2013;126:403-413. doi: 10.1242/jcs.109447.
132. Craig R, Smith R, Kendrick-Jones J. Light-chain phosphorylation controls the conformation of vertebrate non-muscle and smooth muscle myosin molecules. Nature. 1983;302:436-439.
133. Kolega J. Cytoplasmic dynamics of myosin IIA and IIB: spatial 'sorting' of isoforms in locomoting cells. J Cell Sci. 1998;111(pt 15):2085-2095.
134. Kim TJ, Zheng S, Sun J, Muhamed I, Wu J, Lei L, Kong X, Leckband DE, Wang Y Dynamic visualization of a-catenin reveals rapid, reversible conformation switching between tension states. Curr Biol. 2015;25:218-224. doi: 10.1016/j.cub.2014.11.017.
135. Niederman R, Pollard TD. Human platelet myosin. II. In vitro assembly and structure of myosin flaments. J Cell Biol. 1975;67:72-92.
136. Shimokawa H, Seto M, Katsumata N, Amano M, Kozai T, Yamawaki T, Kuwata K, Kandabashi T, Egashira K, Ikegaki I, Asano T, Kaibuchi K, Takeshita A. Rho-kinase-mediated pathway induces enhanced myosin light chain phosphorylations in a swine model of coronary artery spasm. Cardiovasc Res. 1999;43:1029-1039.
137. Wu SK, Gomez GA, Michael M, Verma S, Cox HL, Lefevre JG, Parton RG, Hamilton NA, Neufeld Z, Yap AS. Cortical F-actin stabilization generates apical-lateral patterns of junctional contractility that integrate cells into epithelia. Nat Cell Biol. 2014;16:167-178. doi: 10.1038/ncb2900.
138. Rajput C, Kini V, Smith M, Yazbeck P, Chavez A, Schmidt T, Zhang W, Knezevic N, Komarova Y, Mehta D. Neural Wiskott-Aldrich syndrome protein (N-WASP)-mediated p120-catenin interaction with Arp2-Actin complex stabilizes endothelial adherens junctions. J Biol Chem. 2013;288:4241-4250. doi: 10.1074/jbc.M112.440396.
139. Tang VW, Brieher WM. FSGS3/CD2AP is a barbed-end capping protein that stabilizes actin and strengthens adherens junctions. J Cell Biol. 2013;203:815-833. doi: 10.1083/jcb.201304143.
140. Leckband DE, de Rooij J. Cadherin adhesion and mechanotrans-duction. Annu Rev Cell Dev Biol. 2014;30:291-315. doi: 10.1146/ annurev-cellbio-100913-013212.
141. Yamada S, Pokutta S, Drees F, Weis WI, Nelson WJ. Deconstructing the cadherin-catenin-actin complex. Cell. 2005;123:889-901. doi: 10.1016/j. cell.2005.09.020.
142. Conway DE, Breckenridge MT, Hinde E, Gratton E, Chen CS, Schwartz MA. Fluid shear stress on endothelial cells modulates mechanical tension across VE-cadherin and PECAM-1. Curr Biol. 2013;23:1024-1030. doi: 10.1016/j.cub.2013.04.049.
143. Hill DK. Tension due to interaction between the sliding flaments in resting striated muscle. The effect of stimulation. J Physiol. 1968;199:637-684.
144. Simons M, Wang M, McBride OW, Kawamoto S, Yamakawa K, Gdula D, Adelstein RS, Weir L. Human nonmuscle myosin heavy chains are encoded by two genes located on different chromosomes. Circ Res. 1991;69:530-539.
145. Higashi-Fujime S. Active movement of bundles of actin and myosin fla-ments from muscle: a simple model for cell motility. Cold Spring Harb Symp Quant Biol. 1982;46(pt 1):69-75.
146. Goeckeler ZM, Wysolmerski RB. Myosin light chain kinase-regulated endothelial cell contraction: the relationship between isometric tension, actin polymerization, and myosin phosphorylation. J Cell Biol. 1995;130:613-627.
147. Miller JR, Silver PJ, Stull JT. The role of myosin light chain kinase phos-phorylation in beta-adrenergic relaxation of tracheal smooth muscle. Mol Pharmacol. 1983;24:235-242.
148. Birukov KG, Csortos C, Marzilli L, Dudek S, Ma SF, Bresnick AR, Verin AD, Cotter RJ, Garcia JG. Differential regulation of alternatively spliced endothelial cell myosin light chain kinase isoforms by p60(Src). J Biol Chem. 2001;276:8567-8573. doi: 10.1074/jbc.M005270200.
149. Feng J, Ito M, Ichikawa K, Isaka N, Nishikawa M, Hartshorne DJ, Nakano T. Inhibitory phosphorylation site for Rho-associated kinase on smooth muscle myosin phosphatase. J Biol Chem. 1999;274:37385-37390.
150. van Nieuw Amerongen GP, van Delft S, Vermeer MA, Collard JG, van Hinsbergh VW. Activation of RhoA by thrombin in endothelial hyper-permeability: role of Rho kinase and protein tyrosine kinases. Circ Res. 2000;87:335-340.
151. van Nieuw Amerongen GP, Beckers CM, Achekar ID, Zeeman S, Musters RJ, van Hinsbergh VW. Involvement of Rho kinase in endothelial barrier maintenance. Arterioscler Thromb Vasc Biol. 2007;27:2332-2339. doi: 10.1161/ATVBAHA.107.152322.
152. Reinhard NR, van Helden SF, Anthony EC, Yin T, Wu YI, Goedhart J, Gadella TW, Hordijk PL. Spatiotemporal analysis of RhoA/B/C activation in primary human endothelial cells. Sci Rep. 2016;6:25502. doi: 10.1038/srep25502.
153. Szulcek R, Beckers CM, Hodzic J, de Wit J, Chen Z, Grob T, Musters RJ, Minshall RD, van Hinsbergh VW, van Nieuw Amerongen GP. Localized RhoA GTPase activity regulates dynamics of endothelial monolayer integrity. Cardiovasc Res. 2013;99:471-482. doi: 10.1093/cvr/cvt075.
154. Smith AL, Dohn MR, Brown M V, Reynolds AB. Association of Rho-associated protein kinase 1 with E-cadherin complexes is mediated by p120-catenin. Mol Biol Cell. 2012;23:99-110. doi: 10.1091/mbc. E11-06-0497.
155. Priya R, Yap AS, Gomez GA. E-cadherin supports steady-state Rho signaling at the epithelial zonula adherens. Differentiation. 2013;86:133-140. doi: 10.1016/j.diff.2013.01.002.
156. Priya R, Gomez GA, Budnar S, Verma S, Cox HL, Hamilton NA, Yap AS. Feedback regulation through myosin II confers robustness on RhoA signalling at E-cadherin junctions. Nat Cell Biol. 2015;17:1282-1293. doi: 10.1038/ncb3239.
157. Siddiqui MR, Komarova YA, Vogel SM, Gao X, Bonini MG, Rajasingh J, Zhao YY, Brovkovych V, Malik AB. Caveolin-1-eNOS signaling promotes p190RhoGAP-A nitration and endothelial permeability. J Cell Biol. 2011;193:841-850. doi: 10.1083/jcb.201012129.
158. Chava KR, Tauseef M, Sharma T, Mehta D. Cyclic AMP response element-binding protein prevents endothelial permeability increase through transcriptional controlling p190RhoGAP expression. Blood. 2012;119:308-319. doi: 10.1182/blood-2011-02-339473.
159. Zebda N, Tian Y, Tian X, Gawlak G, Higginbotham K, Reynolds AB, Birukova AA, Birukov KG. Interaction of p190RhoGAP with C-terminal domain of p120-catenin modulates endothelial cytoskeleton and permeability. J Biol Chem. 2013;288:18290-18299. doi: 10.1074/jbc. M112.432757.
160. Wilkinson S, Paterson HF, Marshall CJ. Cdc42-MRCK and Rho-ROCK signalling cooperate in myosin phosphorylation and cell invasion. Nat Cell Biol. 2005;7:255-261. doi: 10.1038/ncb1230.
161. Vogler G, Liu J, Iafe TW, Migh E, Mihály J, Bodmer R. Cdc42 and for-min activity control non-muscle myosin dynamics during Drosophila heart morphogenesis. J Cell Biol. 2014;206:909-922. doi: 10.1083/ jcb.201405075.
162. Koh W, Mahan RD, Davis GE. Cdc42- and Rac1-mediated endothelial lumen formation requires Pak2, Pak4 and Par3, and PKC-dependent signaling. J Cell Sci. 2008;121:989-1001. doi: 10.1242/jcs.020693.
163. Barry DM, Xu K, Meadows SM, Zheng Y, Norden PR, Davis GE, Cleaver O. Cdc42 is required for cytoskeletal support of endothelial cell adhesion during blood vessel formation in mice. Development. 2015;142:3058-3070. doi: 10.1242/dev.125260.
164. Baeyens N, Bandyopadhyay C, Coon BG, Yun S, Schwartz MA. Endothelial fuid shear stress sensing in vascular health and disease. J Clin Invest. 2016;126:821-828. doi: 10.1172/JCI83083.
165. Tzima E, Irani-Tehrani M, Kiosses WB, Dejana E, Schultz DA, Engelhardt B, Cao G, DeLisser H, Schwartz MA. A mechanosensory complex that mediates the endothelial cell response to fuid shear stress. Nature. 2005;437:426-431. doi: 10.1038/nature03952.
166. Coon BG, Baeyens N, Han J, Budatha M, Ross TD, Fang JS, Yun S, Thomas JL, Schwartz MA. Intramembrane binding of VE-cadherin to VEGFR2 and VEGFR3 assembles the endothelial mechanosensory complex. J Cell Biol. 2015;208:975-986. doi: 10.1083/jcb.201408103.
167. Noria S, Cowan DB, Gotlieb AI, Langille BL. Transient and steady-state effects of shear stress on endothelial cell adherens junctions. Circ Res. 1999;85:504-514.
168. Miao H, Hu YL, Shiu YT, Yuan S, Zhao Y, Kaunas R, Wang Y, Jin G, Usami S, Chien S. Effects of fow patterns on the localization and expression of VE-cadherin at vascular endothelial cell junctions: in vivo and in vitro investigations. J Vasc Res. 2005;42:77-89. doi: 10.1159/000083094.
169. Orsenigo F, Giampietro C, Ferrari A, et al. Phosphorylation of VE-cadherin is modulated by haemodynamic forces and contributes to the regulation of vascular permeability in vivo. Nat Commun. 2012;3:1208. doi: 10.1038/ncomms2199.
170. Liu B, Lu S, Hu YL, Liao X, Ouyang M, Wang Y. RhoA and membrane fuidity mediates the spatially polarized Src/FAK activation in response to shear stress. Sci Rep. 2014;4:7008. doi: 10.1038/srep07008.
171. Chiu YJ, McBeath E, Fujiwara K. Mechanotransduction in an extracted cell model: Fyn drives stretch- and fow-elicited PECAM-1 phosphoryla-tion. J Cell Biol. 2008;182:753-763. doi: 10.1083/jcb.200801062.
172. Fleming I, Fisslthaler B, Dixit M, Busse R. Role of PECAM-1 in the shear-stress-induced activation of Akt and the endothelial nitric oxide synthase (eNOS) in endothelial cells. J Cell Sci. 2005;118:4103-4111. doi: 10.1242/jcs.02541.
173. Cain RJ, Vanhaesebroeck B, Ridley AJ. The PI3K p110alpha isoform regulates endothelial adherens junctions via Pyk2 and Rac1. J Cell Biol. 2010;188:863-876. doi: 10.1083/jcb.200907135.
174. Liu Y, Collins C, Kiosses WB, Murray AM, Joshi M, Shepherd TR, Fuentes EJ, Tzima E. A novel pathway spatiotemporally activates Rac1 and redox signaling in response to fuid shear stress. J Cell Biol. 2013;201:863-873. doi: 10.1083/jcb.201207115.
175. rd, Reader JS, Burridge K, Superfne R, Tzima E. Haemodynamic and extracellular matrix cues regulate the mechanical phenotype and stiffness of aortic endo-thelial cells. Nat Commun. 2014;5:3984. doi: 10.1038/ncomms4984.
176. Guilluy C, Swaminathan V, Garcia-Mata R, O'Brien ET, Superfne R, Burridge K. The Rho GEFs LARG and GEF-H1 regulate the mechanical response to force on integrins. Nat Cell Biol. 2011;13:722-727. doi: 10.1038/ncb2254.
177. Collins C, Guilluy C, Welch C, O'Brien ET, Hahn K, Superfne R, Burridge K, Tzima E. Localized tensional forces on PECAM-1 elicit a global mechanotransduction response via the integrin-RhoA pathway. Curr Biol. 2012;22:2087-2094. doi: 10.1016/j.cub.2012.08.051.
178. Orr AW, Ginsberg MH, Shattil SJ, Deckmyn H, Schwartz MA. Matrix-specifc suppression of integrin activation in shear stress signaling. Mol Biol Cell. 2006;17:4686-4697. doi: 10.1091/mbc.E06-04-0289.
179. Whittard JD, Akiyama SK. Positive regulation of cell-cell and cell-substrate adhesion by protein kinase A. J Cell Sci. 2001;114:3265-3272.
180. Qiao J, Huang F, Lum H. PKA inhibits RhoA activation: a protection mechanism against endothelial barrier dysfunction. Am J Physiol Lung Cell Mol Physiol. 2003;284:L972-L980. doi: 10.1152/ ajplung.00429.2002.
181. Ellerbroek SM, Wennerberg K, Burridge K. Serine phosphorylation negatively regulates RhoA in vivo. J Biol Chem. 2003;278:19023-19031. doi: 10.1074/jbc.M213066200.
182. Daneshjou N, Sieracki N, van Nieuw Amerongen GP, Schwartz MA, Komarova YA, Malik AB, Conway DE. Rac1 functions as a reversible tension modulator to stabilize VE-cadherin trans-interaction. J Cell Biol. 2015;208:23-32. doi: 10.1083/jcb.201409108.
183. Hashizume H, Baluk P, Morikawa S, McLean JW, Thurston G, Roberge S, Jain RK, McDonald DM. Openings between defective endothelial cells explain tumor vessel leakiness. Am J Pathol. 2000;156:1363-1380. doi: 10.1016/S0002-9440(10)65006-7.
184. Xiao K, Garner J, Buckley KM, Vincent PA, Chiasson CM, Dejana E, Faundez V, Kowalczyk AP. p120-Catenin regulates clathrin-dependent endocytosis of VE-cadherin. Mol Biol Cell. 2005;16:5141-5151. doi: 10.1091/mbc.E05-05-0440.
185. Alcaide P, Newton G, Auerbach S, Sehrawat S, Mayadas TN, Golan DE, Yacono P, Vincent P, Kowalczyk A, Luscinskas FW. p120-Catenin regulates leukocyte transmigration through an effect on VE-cadherin phosphorylation. Blood. 2008;112:2770-2779. doi: 10.1182/ blood-2008-03-147181.
186. Alcaide P, Martinelli R, Newton G, Williams MR, Adam A, Vincent PA, Luscinskas FW. p120-Catenin prevents neutrophil transmigration independently of RhoA inhibition by impairing Src dependent VE-cadherin phosphorylation. Am J Physiol Cell Physiol. 2012;303:C385-C395. doi: 10.1152/ajpcell.00126.2012.
187. Heupel WM, Efthymiadis A, Schlegel N, Müller T, Baumer Y, Baumgartner W, Drenckhahn D, Waschke J. Endothelial barrier stabilization by a cyclic tandem peptide targeting VE-cadherin transinterac-tion in vitro and in vivo. J Cell Sci. 2009;122:1616-1625. doi: 10.1242/ jcs.040212.
188. Gavard J, Gutkind JS. VEGF controls endothelial-cell permeability by promoting the beta-arrestin-dependent endocytosis of VE-cadherin. Nat Cell Biol. 2006;8:1223-1234. doi: 10.1038/ncb1486.
189. Vandenbroucke St Amant E, Tauseef M, Vogel SM, Gao XP, Mehta D, Komarova YA, Malik AB. Pkcalpha activation of p120-catenin serine 879 phospho-switch disassembles ve-cadherin junctions and disrupts vascular integrity. Circ Res. 2012;111:739-749
190. Gong H, Gao X, Feng S, Siddiqui MR, Garcia A, Bonini MG, Komarova Y, Vogel SM, Mehta D, Malik AB. Evidence of a common mechanism of disassembly of adherens junctions through Gα13 targeting of VE-cadherin. J Exp Med. 2014;211:579-591. doi: 10.1084/ jem.20131190.
191. Eliceiri BP, Paul R, Schwartzberg PL, Hood JD, Leng J, Cheresh DA. Selective requirement for Src kinases during VEGF-induced angiogen-esis and vascular permeability. Mol Cell. 1999;4:915-924.
192. Roura S, Miravet S, Piedra J, García de Herreros A, Duñach M. Regulation of E-cadherin/Catenin association by tyrosine phosphoryla-tion. J Biol Chem. 1999;274:36734-36740.
193. Piedra J, Miravet S, Castaño J, Pálmer HG, Heisterkamp N, García de Herreros A, Duñach M. p120 Catenin-associated Fer and Fyn tyrosine kinases regulate beta-catenin Tyr-142 phosphorylation and beta-catenin-alpha-catenin interaction. Mol Cell Biol. 2003;23:2287-2297.
194. Han J, Zhang G, Welch EJ, Liang Y, Fu J, Vogel SM, Lowell CA, Du X, Cheresh DA, Malik AB, Li Z. A critical role for Lyn kinase in strengthening endothelial integrity and barrier function. Blood. 2013;122:4140-4149. doi: 10.1182/blood-2013-03-491423.
195. Knezevic N, Tauseef M, Thennes T, Mehta D. The G protein betagamma subunit mediates reannealing of adherens junctions to reverse endothelial permeability increase by thrombin. J Exp Med. 2009;206:2761-2777. doi: 10.1084/jem.20090652.
196. Holinstat M, Knezevic N, Broman M, Samarel AM, Malik AB, Mehta D. Suppression of RhoA activity by focal adhesion kinase-induced activation of p190RhoGAP: role in regulation of endothelial permeability. J Biol Chem. 2006;281:2296-2305. doi: 10.1074/jbc.M511248200.
197. Schmidt TT, Tauseef M, Yue L, Bonini MG, Gothert J, Shen TL, Guan JL, Predescu S, Sadikot R, Mehta D. Conditional deletion of FAK in mice endothelium disrupts lung vascular barrier function due to desta-bilization of RhoA and Rac1 activities. Am J Physiol Lung Cell Mol Physiol. 2013;305:L291-L300. doi: 10.1152/ajplung.00094.2013.
198. Chen XL, Nam JO, Jean C, Lawson C, Walsh CT, Goka E, Lim ST, Tomar A, Tancioni I, Uryu S, Guan JL, Acevedo LM, Weis SM, Cheresh DA, Schlaepfer DD. VEGF-induced vascular permeability is mediated by FAK. Dev Cell. 2012;22:146-157. doi: 10.1016/j.devcel.2011.11.002.
199. Lee J, Borboa AK, Chun HB, Baird A, Eliceiri BP. Conditional deletion of the focal adhesion kinase FAK alters remodeling of the blood-brain barrier in glioma. Cancer Res. 2010;70:10131-10140. doi: 10.1158/0008-5472.CAN-10-2740.
200. Jean C, Chen XL, Nam JO, Tancioni I, Uryu S, Lawson C, Ward KK, Walsh CT, Miller NL, Ghassemian M, Turowski P, Dejana E, Weis S, Cheresh DA, Schlaepfer DD. Inhibition of endothelial FAK activity prevents tumor metastasis by enhancing barrier function. J Cell Biol. 2014;204:247-263. doi: 10.1083/jcb.201307067.
201. Baumeister U, Funke R, Ebnet K, Vorschmitt H, Koch S, Vestweber D. Association of Csk to VE-cadherin and inhibition of cell proliferation. EMBO J. 2005;24:1686-1695. doi: 10.1038/sj.emboj.7600647.
202. Jin H, Garmy-Susini B, Avraamides CJ, Stoletov K, Klemke RL, Varner JA. A PKA-Csk-pp60Src signaling pathway regulates the switch between endothelial cell invasion and cell-cell adhesion during vascular sprouting. Blood. 2010;116:5773-5783. doi: 10.1182/blood-2010-07-296210.
203. Nawroth R, Poell G, Ranft A, Kloep S, Samulowitz U, Fachinger G, Golding M, Shima DT, Deutsch U, Vestweber D. VE-PTP and VE-cadherin ectodomains interact to facilitate regulation of phosphorylation and cell contacts. EMBO J. 2002;21:4885-4895.
204. Nottebaum AF, Cagna G, Winderlich M, Gamp AC, Linnepe R, Polaschegg C, Filippova K, Lyck R, Engelhardt B, Kamenyeva O, Bixel MG, Butz S, Vestweber D. VE-PTP maintains the endothelial barrier via plakoglobin and becomes dissociated from VE-cadherin by leukocytes and by VEGF. J Exp Med. 2008;205:2929-2945. doi: 10.1084/ jem.20080406.
205. Schulte D, Küppers V, Dartsch N, Broermann A, Li H, Zarbock A, Kamenyeva O, Kiefer F, Khandoga A, Massberg S, Vestweber D. Stabilizing the VE-cadherin-catenin complex blocks leukocyte extravasation and vascular permeability. EMBO J. 2011;30:4157-4170. doi: 10.1038/emboj.2011.304.
206. Balsamo J, Arregui C, Leung T, Lilien J. The nonreceptor protein tyro-sine phosphatase PTP1B binds to the cytoplasmic domain of N-cadherin and regulates the cadherin-actin linkage. J Cell Biol. 1998;143:523-532.
207. Timmerman I, Hoogenboezem M, Bennett AM, Geerts D, Hordijk PL, van Buul JD. The tyrosine phosphatase SHP2 regulates recovery of endo-thelial adherens junctions through control of β-catenin phosphorylation. Mol Biol Cell. 2012;23:4212-4225. doi: 10.1091/mbc.E12-01-0038.
208. Shen J, Frye M, Lee BL, et al. Targeting VE-PTP activates TIE2 and stabilizes the ocular vasculature. J Clin Invest. 2014;124:4564-4576. doi: 10.1172/JCI74527.
209. van der Heijden M, van Nieuw Amerongen GP, van Bezu J, Paul MA, Groeneveld AB, van Hinsbergh VW. Opposing effects of the angiopoi-etins on the thrombin-induced permeability of human pulmonary mi-crovascular endothelial cells. PLoS One. 2011;6:e23448. doi: 10.1371/ journal.pone.0023448.
210. Sessa WC, Harrison JK, Barber CM, Zeng D, Durieux ME, D'Angelo DD, Lynch KR, Peach MJ. Molecular cloning and expression of a cDNA encoding endothelial cell nitric oxide synthase. J Biol Chem. 1992;267:15274-15276.
211. Lamas S, Marsden PA, Li GK, Tempst P, Michel T. Endothelial nitric oxide synthase: molecular cloning and characterization of a distinct constitutive enzyme isoform. Proc Natl Acad Sci U S A. 1992;89:6348-6352.
212. Lamas S, Michel T, Collins T, Brenner BM, Marsden PA. Effects of inter-feron-gamma on nitric oxide synthase activity and endothelin-1 production by vascular endothelial cells. J Clin Invest. 1992;90:879-887. doi: 10.1172/JCI115963.
213. Thibeault S, Rautureau Y, Oubaha M, Faubert D, Wilkes BC, Delisle C, Gratton JP. S-nitrosylation of beta-catenin by eNOS-derived NO promotes VEGF-induced endothelial cell permeability. Mol Cell. 2010;39:468-476. doi: 10.1016/j.molcel.2010.07.013.
214. Marín N, Zamorano P, Carrasco R, Mujica P, González FG, Quezada C, Meininger CJ, Boric MP, Durán WN, Sánchez FA. S-Nitrosation of β-catenin and p120 catenin: a novel regulatory mechanism in endo-thelial hyperpermeability. Circ Res. 2012;111:553-563. doi: 10.1161/ CIRCRESAHA.112.274548.
215. Guequén A, Carrasco R, Zamorano P, Rebolledo L, Burboa P, Sarmiento J, Boric MP, Korayem A, Durán WN, Sánchez FA. S-nitrosylation regulates VE-cadherin phosphorylation and internalization in microvascular permeability. Am J Physiol Heart Circ Physiol. 2016;310:H1039-H1044. doi: 10.1152/ajpheart.00063.2016.
216. Stamler JS, Simon DI, Osborne JA, Mullins ME, Jaraki O, Michel T, Singel DJ, Loscalzo J. S-nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds. Proc Natl Acad Sci U S A. 1992;89:444-448.
217. Fukumura D, Gohongi T, Kadambi A, Izumi Y, Ang J, Yun CO, Buerk DG, Huang PL, Jain RK. Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability. Proc Natl Acad Sci U S A. 2001;98:2604-2609. doi: 10.1073/pnas.041359198.
218. Wormall A. The immunological specifcity of chemically altered proteins: halogenated and nitrated proteins. J Exp Med. 1930;51:295-317.
219. Gonzalez D, Rojas A, Herrera MB, Conlan RS. iNOS activation regulates β-catenin association with its partners in endothelial cells. PLoS One. 2012;7:e52964. doi: 10.1371/journal.pone.0052964.
220. Turko IV, Li L, Aulak KS, Stuehr DJ, Chang JY, Murad F. Protein tyrosine nitration in the mitochondria from diabetic mouse heart. Implications to dysfunctional mitochondria in diabetes. J Biol Chem. 2003;278:33972-33977. doi: 10.1074/jbc.M303734200.
221. Beckmann JS, Ye YZ, Anderson PG, Chen J, Accavitti MA, Tarpey MM, White CR. Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry. Biol Chem Hoppe Seyler. 1994;375:81-88.
222. Starr ME, Ueda J, Yamamoto S, Evers BM, Saito H. The effects of aging on pulmonary oxidative damage, protein nitration, and extracellular superoxide dismutase down-regulation during systemic in-fammation. Free Radic Biol Med. 2011;50:371-380. doi: 10.1016/j. freeradbiomed.2010.11.013.
223. Verma N, Tripathi SK, Chaudhury I, Das HR, Das RH. iNOS-tar-geted 10-23 DNAzyme reduces LPS-induced systemic infamma-tion and mortality in mice. Shock. 2010;33:493-499. doi: 10.1097/ SHK.0b013e3181c4ecbb.
224. Nagareddy PR, Xia Z, McNeill JH, MacLeod KM. Increased expression of iNOS is associated with endothelial dysfunction and impaired pressor responsiveness in streptozotocin-induced diabetes. Am J Physiol Heart Circ Physiol. 2005;289:H2144-H2152. doi: 10.1152/ajpheart.00591.2005.
225. Nachtigal P, Kopecky M, Solichova D, Zdansky P, Semecky V. The changes in the endothelial expression of cell adhesion molecules and iNOS in the vessel wall after the short-term administration of simvastatin in rabbit model of atherosclerosis. J Pharm Pharmacol. 2005;57:197-203. doi: 10.1211/0022357055353.
226. Wang X, Xiao Y, Mou Y, Zhao Y, Blankesteijn WM, Hall JL. A role for the beta-catenin/T-cell factor signaling cascade in vascular remodeling. Circ Res. 2002;90:340-347.
227. Yu J, Ma Z, Shetty S, Ma M, Fu J. Selective HDAC6 inhibition prevents TNF-α-induced lung endothelial cell barrier disruption and endo-toxin-induced pulmonary edema. Am J Physiol Lung Cell Mol Physiol. 2016;311:L39-L47. doi: 10.1152/ajplung.00051.2016.
228. Iaconelli J, Huang JH, Berkovitch SS, Chattopadhyay S, Mazitschek R, Schreiber SL, Haggarty SJ, Karmacharya R. HDAC6 inhibitors modulate Lys49 acetylation and membrane localization of β-catenin in human iPSC-derived neuronal cells. ACS Chem Biol. 2015;10:883-890. doi: 10.1021/cb500838r.
229. Wolf D, Rodova M, Miska EA, Calvet JP, Kouzarides T. Acetylation of beta-catenin by CREB-binding protein (CBP). J Biol Chem. 2002;277:25562-25567. doi: 10.1074/jbc.M201196200.
230. Lévy L, Wei Y, Labalette C, Wu Y, Renard CA, Buendia MA, Neuveut C. Acetylation of beta-catenin by p300 regulates beta-catenin-Tcf4 interaction. Mol Cell Biol. 2004;24:3404-3414.
231. Chattopadhyay S, Fensterl V, Zhang Y, Veleeparambil M, Wetzel JL, Sen GC. Inhibition of viral pathogenesis and promotion of the septic shock response to bacterial infection by irf-3 are regulated by the acetylation and phosphorylation of its coactivators. mBio. 2013;4.
232. Nguyen LT, Lum H, Tiruppathì C, Malik AB. Site-specifc thrombin receptor antibodies inhibit Ca2+ signaling and increased endothelial permeability. Am J Physiol. 1997;273:C1756-C1763.
233. Geyer M, Huang F, Sun Y, Vogel SM, Malik AB, Taylor CW, Komarova YA. Microtubule-Associated Protein EB3 Regulates IP3 Receptor Clustering and Ca(2+) Signaling in Endothelial Cells. Cell Rep. 2015;12:79-89. doi: 10.1016/j.celrep.2015.06.001.
234. Tauseef M, Knezevic N, Chava KR, Smith M, Sukriti S, Gianaris N, Obukhov AG, Vogel SM, Schraufnagel DE, Dietrich A, Birnbaumer L, Malik AB, Mehta D. TLR4 activation of TRPC6-dependent calcium signaling mediates endotoxin-induced lung vascular permeability and infammation. J Exp Med. 2012;209:1953-1968. doi: 10.1084/ jem.20111355.
235. Kini V, Chavez A, Mehta D. A new role for PTEN in regulating transient receptor potential canonical channel 6-mediated Ca2+ entry, endothelial permeability, and angiogenesis. J Biol Chem. 2010;285:33082-33091. doi: 10.1074/jbc.M110.142034.
236. Singh I, Knezevic N, Ahmmed GU, Kini V, Malik AB, Mehta D. Galphaq-TRPC6-mediated Ca2+ entry induces RhoA activation and resultant endothelial cell shape change in response to thrombin. J Biol Chem. 2007;282:7833-7843. doi: 10.1074/jbc.M608288200.
237. Yip H, Chan WY, Leung PC, Kwan HY, Liu C, Huang Y, Michel V, Yew DT, Yao X. Expression of TRPC homologs in endothelial cells and smooth muscle layers of human arteries. Histochem Cell Biol. 2004;122:553-561. doi: 10.1007/s00418-004-0720-y.
238. Mehta D, Ahmmed GU, Paria BC, Holinstat M, Voyno-Yasenetskaya T, Tiruppathi C, Minshall RD, Malik AB. RhoA interaction with inositol 1,4,5-trisphosphate receptor and transient receptor potential channel-1 regulates Ca2+ entry. Role in signaling increased endothelial permeability. J Biol Chem. 2003;278:33492-33500. doi: 10.1074/jbc.M302401200.
239. Smedlund K, Vazquez G. Involvement of native TRPC3 proteins in ATP-dependent expression of VCAM-1 and monocyte adherence in coronary artery endothelial cells. Arterioscler Thromb Vasc Biol. 2008;28:2049-2055. doi: 10.1161/ATVBAHA.108.175356.
240. Tiruppathi C, Freichel M, Vogel SM, Paria BC, Mehta D, Flockerzi V, Malik AB. Impairment of store-operated Ca2+ entry in TRPC4(-/-) mice interferes with increase in lung microvascular permeability. Circ Res. 2002;91:70-76.
241. Sundivakkam PC, Freichel M, Singh V, Yuan JP, Vogel SM, Flockerzi V, Malik AB, Tiruppathi C. The Ca(2+) sensor stromal interaction molecule 1 (STIM1) is necessary and suffcient for the store-operated Ca(2+) entry function of transient receptor potential canonical (TRPC) 1 and 4 channels in endothelial cells. Mol Pharmacol. 2012;81:510-526. doi: 10.1124/mol.111.074658.
242. Jho D, Mehta D, Ahmmed G, Gao XP, Tiruppathi C, Broman M, Malik AB. Angiopoietin-1 opposes VEGF-induced increase in endothe-lial permeability by inhibiting TRPC1-dependent Ca2 infux. Circ Res. 2005;96:1282-1290. doi: 10.1161/01.RES.0000171894.03801.03.
243. Pocock TM, Foster RR, Bates DO. Evidence of a role for TRPC channels in VEGF-mediated increased vascular permeability in vivo. Am J Physiol Heart Circ Physiol. 2004;286:H1015-H1026. doi: 10.1152/ ajpheart.00826.2003.
244. Nilius B, Droogmans G. Ion channels and their functional role in vascular endothelium. Physiol Rev. 2001;81:1415-1459.
245. Montell C, Birnbaumer L, Flockerzi V. The TRP channels, a remarkably functional family. Cell. 2002;108:595-598.
246. Tauseef M, Farazuddin M, Sukriti S, Rajput C, Meyer JO, Ramasamy SK, Mehta D. Transient receptor potential channel 1 maintains adher-ens junction plasticity by suppressing sphingosine kinase 1 expression to induce endothelial hyperpermeability. FASEB J. 2016;30:102-110. doi: 10.1096/fj.15-275891.
247. Hofmann T, Obukhov AG, Schaefer M, Harteneck C, Gudermann T, Schultz G. Direct activation of human TRPC6 and TRPC3 channels by diacylglycerol. Nature. 1999;397:259-263. doi: 10.1038/16711.
248. Aires V, Hichami A, Boulay G, Khan NA. Activation of TRPC6 calcium channels by diacylglycerol (DAG)-containing arachidonic acid: a comparative study with DAG-containing docosahexaenoic acid. Biochimie. 2007;89:926-937. doi: 10.1016/j.biochi.2006.10.016.
249. Chen W, Oberwinkler H, Werner F, Gaßner B, Nakagawa H, Feil R, Hofmann F, Schlossmann J, Dietrich A, Gudermann T, Nishida M, Del Galdo S, Wieland T, Kuhn M. Atrial natriuretic peptide-mediated inhibition of microcirculatory endothelial Ca2+ and permeability response to histamine involves cGMP-dependent protein kinase I and TRPC6 channels. Arterioscler Thromb Vasc Biol. 2013;33:2121-2129. doi: 10.1161/ ATVBAHA.113.001974.
250. Weber EW, Han F, Tauseef M, Birnbaumer L, Mehta D, Muller WA. TRPC6 is the endothelial calcium channel that regulates leukocyte tran-sendothelial migration during the infammatory response. J Exp Med. 2015;212:1883-1899. doi: 10.1084/jem.20150353.
251. Colbert HA, Smith TL, Bargmann CI. OSM-9, a novel protein with structural similarity to channels, is required for olfaction, mechanosen-sation, and olfactory adaptation in Caenorhabditis elegans. J Neurosci. 1997;17:8259-8269.
252. Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature. 1997;389:816-824. doi: 10.1038/39807.
253. Alvarez DF, King JA, Weber D, Addison E, Liedtke W, Townsley MI. Transient receptor potential vanilloid 4-mediated disruption of the alveolar septal barrier: a novel mechanism of acute lung injury. Circ Res. 2006;99:988-995. doi: 10.1161/01.RES.0000247065.11756.19.
254. Watanabe H, Davis JB, Smart D, Jerman JC, Smith GD, Hayes P, Vriens J, Cairns W, Wissenbach U, Prenen J, Flockerzi V, Droogmans G, Benham CD, Nilius B. Activation of TRPV4 channels (hVRL-2/ mTRP12) by phorbol derivatives. J Biol Chem. 2002;277:13569-13577. doi: 10.1074/jbc.M200062200.
255. Watanabe H, Vriens J, Suh SH, Benham CD, Droogmans G, Nilius B. Heat-evoked activation of TRPV4 channels in a HEK293 cell expression system and in native mouse aorta endothelial cells. J Biol Chem. 2002;277:47044-47051. doi: 10.1074/jbc.M208277200.
256. Yin J, Hoffmann J, Kaestle SM, Neye N, Wang L, Baeurle J, Liedtke W, Wu S, Kuppe H, Pries AR, Kuebler WM. Negative-feedback loop attenuates hydrostatic lung edema via a cGMP-dependent regulation of transient receptor potential vanilloid 4. Circ Res. 2008;102:966-974. doi: 10.1161/CIRCRESAHA.107.168724.
257. Perraud AL, Fleig A, Dunn CA, Bagley LA, Launay P, Schmitz C, Stokes AJ, Zhu Q, Bessman MJ, Penner R, Kinet JP, Scharenberg AM. ADP-ribose gating of the calcium-permeable LTRPC2 channel revealed by Nudix motif homology. Nature. 2001;411:595-599. doi: 10.1038/35079100.
258. Hecquet CM, Ahmmed GU, Vogel SM, Malik AB. Role of TRPM2 channel in mediating H2O2-induced Ca2+ entry and endothe-lial hyperpermeability. Circ Res. 2008;102:347-355. doi: 10.1161/ CIRCRESAHA.107.160176.
259. Launay P, Fleig A, Perraud AL, Scharenberg AM, Penner R, Kinet JP. TRPM4 is a Ca2+-activated nonselective cation channel mediating cell membrane depolarization. Cell. 2002;109:397-407.
260. Fantozzi I, Zhang S, Platoshyn O, Remillard CV, Cowling RT, Yuan JX. Hypoxia increases AP-1 binding activity by enhancing capacita-tive Ca2+ entry in human pulmonary artery endothelial cells. Am J Physiol Lung Cell Mol Physiol. 2003;285:L1233-L1245. doi: 10.1152/ ajplung.00445.2002.
261. Sano Y, Inamura K, Miyake A, Mochizuki S, Yokoi H, Matsushime H, Furuichi K. Immunocyte Ca2+ infux system mediated by LTRPC2. Science. 2001;293:1327-1330. doi: 10.1126/science.1062473.
262. Andersen PR, Devare SG, Tronick SR, Ellis RW, Aaronson SA, Scolnick EM. Generation of BALB-MuSV and Ha-MuSC by type C virus trans-duction of homologous transforming genes from different species. Cell. 1981;26:129-134.
263. Hillig RC, Hanzal-Bayer M, Linari M, Becker J, Wittinghofer A, Renault L. Structural and biochemical properties show ARL3-GDP as a distinct GTP binding protein. Structure. 2000;8:1239-1245.
264. Braga VM, Machesky LM, Hall A, Hotchin NA. The small GTPases Rho and Rac are required for the establishment of cadherin-dependent cell-cell contacts. J Cell Biol. 1997;137:1421-1431.
265. Kiosses WB, McKee NH, Kalnins VI. Relationship between the distribution of stress fbers and centrosomes in endothelial cells of the rat aorta. Cell Motil Cytoskeleton. 1997;36:228-235. doi: 10.1002/ (SICI)1097-0169(1997)36:3<228::AID-CM3>3.0.CO;2-3.
266. Maekawa M, Ishizaki T, Boku S, Watanabe N, Fujita A, Iwamatsu A, Obinata T, Ohashi K, Mizuno K, Narumiya S. Signaling from Rho to the actin cytoskeleton through protein kinases ROCK and LIM-kinase. Science. 1999;285:895-898.
267. Sells MA, Boyd JT, Chernoff J. p21-activated kinase 1 (Pak1) regulates cell motility in mammalian fbroblasts. J Cell Biol. 1999;145:837-849.
268. Timpson P, Jones GE, Frame MC, Brunton VG. Coordination of cell polarization and migration by the Rho family GTPases requires Src tyrosine kinase activity. Curr Biol. 2001;11:1836-1846.
269. Yamada S, Nelson WJ. Localized zones of Rho and Rac activities drive initiation and expansion of epithelial cell-cell adhesion. J Cell Biol. 2007;178:517-527.
270. Lampugnani MG, Zanetti A, Breviario F, Balconi G, Orsenigo F, Corada M, Spagnuolo R, Betson M, Braga V, Dejana E. VE-cadherin regulates endothelial actin activating Rac and increasing membrane association of Tiam. Mol Biol Cell. 2002;13:1175-1189. doi: 10.1091/mbc.01-07-0368.
271. Roll-Mecak A, Cao C, Dever TE, Burley SK. X-Ray structures of the universal translation initiation factor IF2/eIF5B: conformational changes on GDP and GTP binding. Cell. 2000;103:781-792.
272. Prakash B, Praefcke GJ, Renault L, Wittinghofer A, Herrmann C. Structure of human guanylate-binding protein 1 representing a unique class of GTP-binding proteins. Nature. 2000;403:567-571. doi: 10.1038/35000617.
273. Vetter IR, Wittinghofer A. The guanine nucleotide-binding switch in three dimensions. Science. 2001;294:1299-1304. doi: 10.1126/ science.1062023.
274. Colicelli J. Human RAS superfamily proteins and related GTPases. Sci STKE. 2004;2004:RE13. doi: 10.1126/stke.2502004re13.
275. Ihara K, Muraguchi S, Kato M, Shimizu T, Shirakawa M, Kuroda S, Kaibuchi K, Hakoshima T. Crystal structure of human RhoA in a dominantly active form complexed with a GTP analogue. J Biol Chem. 1998;273:9656-9666.
276. Wei Y, Zhang Y, Derewenda U, Liu X, Minor W, Nakamoto RK, Somlyo AV, Somlyo AP, Derewenda ZS. Crystal structure of RhoA-GDP and its functional implications. Nat Struct Biol. 1997;4:699-703.
277. John J, Frech M, Wittinghofer A. Biochemical properties of Ha-ras encoded p21 mutants and mechanism of the autophosphorylation reaction. J Biol Chem. 1988;263:11792-11799.
278. Neal SE, Eccleston JF, Hall A, Webb MR. Kinetic analysis of the hydrolysis of GTP by p21N-ras. The basal GTPase mechanism. J Biol Chem. 1988;263:19718-19722.
279. Garrett MD, Self AJ, van Oers C, Hall A. Identification of distinct cyto-plasmic targets for ras/R-ras and rho regulatory proteins. J Biol Chem. 1989;264:10-13.
280. Sasaki T, Kikuchi A, Araki S, Hata Y, Isomura M, Kuroda S, Takai Y. Purifcation and characterization from bovine brain cytosol of a protein that inhibits the dissociation of GDP from and the subsequent binding of GTP to smg p25A, a ras p21-like GTP-binding protein. J Biol Chem. 1990;265:2333-2337.
281. Ueda T, Kikuchi A, Ohga N, Yamamoto J, Takai Y. Purifcation and characterization from bovine brain cytosol of a novel regulatory protein inhibiting the dissociation of GDP from and the subsequent binding of GTP to rhoB p20, a ras p21-like GTP-binding protein. J Biol Chem. 1990;265:9373-9380.
282. Hart MJ, Eva A, Evans T, Aaronson SA, Cerione RA. Catalysis of gua-nine nucleotide exchange on the CDC42Hs protein by the dbl oncogene product. Nature. 1991;354:311-314. doi: 10.1038/354311a0.
283. Hart MJ, Eva A, Zangrilli D, Aaronson SA, Evans T, Cerione RA, Zheng Y. Cellular transformation and guanine nucleotide exchange activity are catalyzed by a common domain on the dbl oncogene product. J Biol Chem. 1994;269:62-65.
284. Hoffman GR, Nassar N, Cerione RA. Structure of the Rho family GTP-binding protein Cdc42 in complex with the multifunctional regulator RhoGDI. Cell. 2000;100:345-356.
285. Scheffzek K, Stephan I, Jensen ON, Illenberger D, Gierschik P. The Rac-RhoGDI complex and the structural basis for the regulation of Rho proteins by RhoGDI. Nat Struct Biol. 2000;7:122-126. doi: 10.1038/72392.
286. del Pozo MA, Alderson NB, Kiosses WB, Chiang HH, Anderson RG, Schwartz MA. Integrins regulate Rac targeting by internaliza-tion of membrane domains. Science. 2004;303:839-842. doi: 10.1126/ science.1092571.
287. Michaely PA, Mineo C, Ying YS, Anderson RG. Polarized distribution of endogenous Rac1 and RhoA at the cell surface. J Biol Chem. 1999;274:21430-21436.
288. Roberts PJ, Mitin N, Keller PJ, Chenette EJ, Madigan JP, Currin RO, Cox AD, Wilson O, Kirschmeier P, Der CJ. Rho Family GTPase modifcation and dependence on CAAX motif-signaled posttranslational modifcation. J Biol Chem. 2008;283:25150-25163. doi: 10.1074/jbc.M800882200.
289. Adamson P, Marshall CJ, Hall A, Tilbrook PA. Post-translational modif-cations of p21rho proteins. J Biol Chem. 1992;267:20033-20038.
290. Michaelson D, Silletti J, Murphy G, D'Eustachio P, Rush M, Philips MR. Differential localization of Rho GTPases in live cells: regulation by hy-pervariable regions and RhoGDI binding. J Cell Biol. 2001;152:111-126.
291. Moissoglu K, Kiessling V, Wan C, Hoffman BD, Norambuena A, Tamm LK, Schwartz MA. Regulation of Rac1 translocation and activation by membrane domains and their boundaries. J Cell Sci. 2014;127:2565-2576. doi: 10.1242/jcs.149088.
292. Wirth A, Schroeter M, Kock-Hauser C, Manser E, Chalovich JM, De Lanerolle P, Pftzer G. Inhibition of contraction and myosin light chain phosphorylation in guinea-pig smooth muscle by p21-activated kinase 1. J Physiol. 2003;549:489-500. doi: 10.1113/jphysiol.2002.033167.
293. Ridley AJ. Life at the leading edge. Cell. 2011;145:1012-1022. doi: 10.1016/j.cell.2011.06.010.
294. Komarova YA, Mehta D, Malik AB. Dual regulation of endothe-lial junctional permeability. Sci STKE. 2007;2007:re8. doi: 10.1126/ stke.4122007re8.
295. Even-Faitelson L, Rosenberg M, Ravid S. PAK1 regulates myosin II-B phosphorylation, flament assembly, localization and cell chemotaxis. Cell Signal. 2005;17:1137-1148. doi: 10.1016/j.cellsig.2004.12.015.
296. Naikawadi RP, Cheng N, Vogel SM, Qian F, Wu D, Malik AB, Ye RD. A critical role for phosphatidylinositol (3,4,5)-trisphosphate-dependent Rac exchanger 1 in endothelial junction disruption and vascular hy-perpermeability. Circ Res. 2012;111:1517-1527. doi: 10.1161/ CIRCRESAHA.112.273078.
297. Edwards DC, Sanders LC, Bokoch GM, Gill GN. Activation of LIM-kinase by Pak1 couples Rac/Cdc42 GTPase signalling to actin cytoskel-etal dynamics. Nat Cell Biol. 1999;1:253-259. doi: 10.1038/12963.
298. Yang N, Higuchi O, Ohashi K, Nagata K, Wada A, Kangawa K, Nishida E, Mizuno K. Coflin phosphorylation by LIM-kinase 1 and its role in Rac-mediated actin reorganization. Nature. 1998;393:809-812. doi: 10.1038/31735.
299. Goh WI, Lim KB, Sudhaharan T, Sem KP, Bu W, Chou AM, Ahmed S. mDia1 and WAVE2 proteins interact directly with IRSp53 in flopodia and are involved in flopodium formation. J Biol Chem. 2012;287:4702-4714. doi: 10.1074/jbc.M111.305102.
300. Riveline D, Zamir E, Balaban NQ, Schwarz US, Ishizaki T, Narumiya S, Kam Z, Geiger B, Bershadsky AD. Focal contacts as mechanosen-sors: externally applied local mechanical force induces growth of focal contacts by an mDia1-dependent and ROCK-independent mechanism. J Cell Biol. 2001;153:1175-1186.
301. Broman MT, Kouklis P, Gao X, Ramchandran R, Neamu RF, Minshall RD, Malik AB. Cdc42 regulates adherens junction stability and endo-thelial permeability by inducing alpha-catenin interaction with the vascular endothelial cadherin complex. Circ Res. 2006;98:73-80. doi: 10.1161/01.RES.0000198387.44395.e9.
302. Ramchandran R, Mehta D, Vogel SM, Mirza MK, Kouklis P, Malik AB. Critical role of Cdc42 in mediating endothelial barrier protection in vivo. Am J Physiol Lung Cell Mol Physiol. 2008;295:L363-L369. doi: 10.1152/ajplung.90241.2008.
303. Diebold BA, Fowler B, Lu J, Dinauer MC, Bokoch GM. Antagonistic cross-talk between Rac and Cdc42 GTPases regulates generation of reactive oxygen species. J Biol Chem. 2004;279:28136-28142. doi: 10.1074/ jbc.M313891200.
304. Birukova AA, Tian Y, Dubrovskyi O, Zebda N, Sarich N, Tian X, Wang Y, Birukov KG. VE-cadherin trans-interactions modulate Rac activation and enhancement of lung endothelial barrier by iloprost. J Cell Physiol. 2012;227:3405-3416. doi: 10.1002/jcp.24041.
305. Tan W, Palmby TR, Gavard J, Amornphimoltham P, Zheng Y, Gutkind JS. An essential role for Rac1 in endothelial cell function and vascular development. FASEB J. 2008;22:1829-1838. doi: 10.1096/ fj.07-096438.
306. Mehta D, Konstantoulaki M, Ahmmed GU, Malik AB. Sphingosine 1-phosphate-induced mobilization of intracellular Ca2+ mediates rac activation and adherens junction assembly in endothelial cells. J Biol Chem. 2005;280:17320-17328. doi: 10.1074/jbc.M411674200.
307. Gonzalez E, Kou R, Michel T. Rac1 modulates sphingosine 1-phosphate-mediated activation of phosphoinositide 3-kinase/Akt signaling pathways in vascular endothelial cells. J Biol Chem. 2006;281:3210-3216. doi: 10.1074/jbc.M510434200.
308. Swart-Mataraza JM, Li Z, Sacks DB. IQGAP1 is a component of Cdc42 signaling to the cytoskeleton. J Biol Chem. 2002;277:24753-24763. doi: 10.1074/jbc.M111165200.
309. Zhao YD, Ohkawara H, Rehman J, Wary KK, Vogel SM, Minshall RD, Zhao YY, Malik AB. Bone marrow progenitor cells induce endothelial adherens junction integrity by sphingosine-1-phosphate-mediated Rac1 and Cdc42 signaling. Circ Res. 2009;105:696-704, 8 p following 704. doi: 10.1161/CIRCRESAHA.109.199778.
310. Papaharalambus C, Sajjad W, Syed A, Zhang C, Bergo MO, Alexander RW, Ahmad M. Tumor necrosis factor alpha stimulation of Rac1 activity. Role of isoprenylcysteine carboxylmethyltransferase. J Biol Chem. 2005;280:18790-18796. doi: 10.1074/jbc.M410081200.
311. Knezevic II, Predescu SA, Neamu RF, Gorovoy MS, Knezevic NM, Easington C, Malik AB, Predescu DN. Tiam1 and Rac1 are required for platelet-activating factor-induced endothelial junctional disassembly and increase in vascular permeability. J Biol Chem. 2009;284:5381-5394. doi: 10.1074/jbc.M808958200.
312. Garrett TA, Van Buul JD, Burridge K. VEGF-induced Rac1 activation in endothelial cells is regulated by the guanine nucleotide exchange factor Vav2. Exp Cell Res. 2007;313:3285-3297. doi: 10.1016/j. yexcr.2007.05.027.
313. Wildenberg GA, Dohn MR, Carnahan RH, Davis MA, Lobdell NA, Settleman J, Reynolds AB. p120-catenin and p190RhoGAP regulate cell-cell adhesion by coordinating antagonism between Rac and Rho. Cell. 2006;127:1027-1039. doi: 10.1016/j.cell.2006.09.046.
314. Axelrad TW, Deo DD, Ottino P, Van Kirk J, Bazan NG, Bazan HE, Hunt JD. Platelet-activating factor (PAF) induces activation of matrix metalloproteinase 2 activity and vascular endothelial cell invasion and migration. FASEB J. 2004;18:568-570. doi: 10.1096/fj.03-0479fje.
315. Bussolino F, Camussi G, Aglietta M, Braquet P, Bosia A, Pescarmona G, Sanavio F, D'Urso N, Marchisio PC. Human endothelial cells are target for platelet-activating factor. I. Platelet-activating factor induces changes in cytoskeleton structures. J Immunol. 1987;139:2439-2446.
316. van Wetering S, van Buul JD, Quik S, Mul FP, Anthony EC, ten Klooster JP, Collard JG, Hordijk PL. Reactive oxygen species mediate Rac-induced loss of cell-cell adhesion in primary human endothelial cells. J Cell Sci. 2002;115:1837-1846.
317. Andor A, Trülzsch K, Essler M, Roggenkamp A, Wiedemann A, Heesemann J, Aepfelbacher M. YopE of Yersinia, a GAP for Rho GTPases, selectively modulates Rac-dependent actin structures in endo-thelial cells. Cell Microbiol. 2001;3:301-310.
318. Wójciak-Stothard B, Potempa S, Eichholtz T, Ridley AJ. Rho and Rac but not Cdc42 regulate endothelial cell permeability. J Cell Sci. 2001;114:1343-1355.
319. Petrache I, Crow MT, Neuss M, Garcia JG. Central involvement of Rho family GTPases in TNF-alpha-mediated bovine pulmonary endothelial cell apoptosis. Biochem Biophys Res Commun. 2003;306:244-249.
320. Essler M, Amano M, Kruse HJ, Kaibuchi K, Weber PC, Aepfelbacher M. Thrombin inactivates myosin light chain phosphatase via Rho and its target Rho kinase in human endothelial cells. J Biol Chem. 1998;273:21867-21874.
321. Nimnual AS, Taylor LJ, Bar-Sagi D. Redox-dependent downregulation of Rho by Rac. Nat Cell Biol. 2003;5:236-241. doi: 10.1038/ncb938.
322. Sander EE, ten Klooster JP, van Delft S, van der Kammen RA, Collard JG. Rac downregulates Rho activity: reciprocal balance between both GTPases determines cellular morphology and migratory behavior. J Cell Biol. 1999;147:1009-1022.
323. Wojciak-Stothard B, Tsang LY, Haworth SG. Rac and Rho play opposing roles in the regulation of hypoxia/reoxygenation-induced permeability changes in pulmonary artery endothelial cells. Am J Physiol Lung Cell Mol Physiol. 2005;288:L749-L760. doi: 10.1152/ajplung.00361.2004.
324. Watanabe N, Kato T, Fujita A, Ishizaki T, Narumiya S. Cooperation between mDia1 and ROCK in Rho-induced actin reorganization. Nat Cell Biol. 1999;1:136-143. doi: 10.1038/11056.
325. Mong PY, Wang Q. Activation of Rho kinase isoforms in lung endothe-lial cells during infammation. J Immunol. 2009;182:2385-2394. doi: 10.4049/jimmunol.0802811.
326. Beckers CM, Knezevic N, Valent ET, Tauseef M, Krishnan R, Rajendran K, Hardin CC, Aman J, van Bezu J, Sweetnam P, van Hinsbergh VW, Mehta D, van Nieuw Amerongen GP. ROCK2 primes the endothe-lium for vascular hyperpermeability responses by raising baseline junctional tension. Vascul Pharmacol. 2015;70:45-54. doi: 10.1016/j. vph.2015.03.017.
327. Joshi AD, Dimitropoulou C, Thangjam G, Snead C, Feldman S, Barabutis N, Fulton D, Hou Y, Kumar S, Patel V, Gorshkov B, Verin AD, Black SM, Catravas JD. Heat shock protein 90 inhibitors prevent LPS-induced en-dothelial barrier dysfunction by disrupting RhoA signaling. Am J Respir Cell Mol Biol. 2014;50:170-179. doi: 10.1165/rcmb.2012-0496OC.
328. Bogatcheva NV, Zemskova MA, Gorshkov BA, Kim KM, Daglis GA, Poirier C, Verin AD. Ezrin, radixin, and moesin are phosphorylated in response to 2-methoxyestradiol and modulate endothelial hyperperme-ability. Am J Respir Cell Mol Biol. 2011;45:1185-1194. doi: 10.1165/ rcmb.2011-0092OC.
329. Wolfrum S, Dendorfer A, Rikitake Y, Stalker TJ, Gong Y, Scalia R, Dominiak P, Liao JK. Inhibition of Rho-kinase leads to rapid activation of phosphatidylinositol 3-kinase/protein kinase Akt and cardiovascular protection. Arterioscler Thromb Vasc Biol. 2004;24:1842-1847. doi: 10.1161/01.ATV.0000142813.33538.82.
330. Rabiet MJ, Plantier JL, Rival Y, Genoux Y, Lampugnani MG, Dejana E. Thrombin-induced increase in endothelial permeability is associated with changes in cell-to-cell junction organization. Arterioscler Thromb Vasc Biol. 1996;16:488-496.
331. Braga V. The crossroads between cell-cell adhesion and motility. Nat Cell Biol. 2000;2:E182-E184. doi: 10.1038/35036433.
332. Chen H, Paradies NE, Fedor-Chaiken M, Brackenbury R. E-cadherin mediates adhesion and suppresses cell motility via distinct mechanisms. J Cell Sci. 1997;110(pt 3):345-356.
333. Noren NK, Niessen CM, Gumbiner BM, Burridge K. Cadherin engagement regulates Rho family GTPases. J Biol Chem. 2001;276:33305-33308. doi: 10.1074/jbc.C100306200.
334. Kovacs EM, Ali RG, McCormack AJ, Yap AS. E-cadherin homophilic ligation directly signals through Rac and phosphatidylinositol 3-kinase to regulate adhesive contacts. J Biol Chem. 2002;277:6708-6718. doi: 10.1074/jbc.M109640200.
335. Gao Y, Xing J, Streuli M, Leto TL, Zheng Y. Trp(56) of rac1 specifes interaction with a subset of guanine nucleotide exchange factors. J Biol Chem. 2001;276:47530-47541. doi: 10.1074/jbc.M108865200.
336. Abe K, Rossman KL, Liu B, Ritola KD, Chiang D, Campbell SL, Burridge K, Der CJ. Vav2 is an activator of Cdc42, Rac1, and RhoA. J Biol Chem. 2000;275:10141-10149.
337. Fukuyama T, Ogita H, Kawakatsu T, Inagaki M, Takai Y. Activation of Rac by cadherin through the c-Src-Rap1-phosphatidylinositol 3-kinase-Vav2 pathway. Oncogene. 2006;25:8-19. doi: 10.1038/sj.onc.1209010.
338. Timmerman I, Heemskerk N, Kroon J, Schaefer A, van Rijssel J, Hoogenboezem M, van Unen J, Goedhart J, Gadella TW Jr, Yin T, Wu Y, Huveneers S, van Buul JD. A local VE-cadherin and Trio-based signaling complex stabilizes endothelial junctions through Rac1. J Cell Sci. 2015;128:3514. doi: 10.1242/jcs.179424.
339. Kurella VB, Richard JM, Parke CL, Lecour LF Jr, Bellamy HD, Worthylake DK. Crystal structure of the GTPase-activating protein-related domain from IQGAP1. J Biol Chem. 2009;284:14857-14865. doi: 10.1074/jbc.M808974200.
340. Kuroda S, Fukata M, Nakagawa M, Fujii K, Nakamura T, Ookubo T, Izawa I, Nagase T, Nomura N, Tani H, Shoji I, Matsuura Y, Yonehara S, Kaibuchi K. Role of IQGAP1, a target of the small GTPases Cdc42 and Rac1, in regulation of E-cadherin- mediated cell-cell adhesion. Science. 1998;281:832-835.
341. David S, Ghosh CC, Mukherjee A, Parikh SM. Angiopoietin-1 requires IQ domain GTPase-activating protein 1 to activate Rac1 and promote en-dothelial barrier defense. Arterioscler Thromb Vasc Biol. 2011;31:2643-2652. doi: 10.1161/ATVBAHA.111.233189.
342. Bhattacharya M, Su G, Su X, Oses-Prieto JA, Li JT, Huang X, Hernandez H, Atakilit A, Burlingame AL, Matthay MA, Sheppard D. IQGAP1 is necessary for pulmonary vascular barrier protection in murine acute lung injury and pneumonia. Am J Physiol Lung Cell Mol Physiol. 2012;303:L12-L19. doi: 10.1152/ajplung.00375.2011.
343. Mammoto T, Parikh SM, Mammoto A, Gallagher D, Chan B, Mostoslavsky G, Ingber DE, Sukhatme VP. Angiopoietin-1 requires p190 RhoGAP to protect against vascular leakage in vivo. J Biol Chem. 2007;282:23910-23918. doi: 10.1074/jbc.M702169200.
344. Roof RW, Haskell MD, Dukes BD, Sherman N, Kinter M, Parsons SJ. Phosphotyrosine (p-Tyr)-dependent and -independent mechanisms of p190 RhoGAP-p120 RasGAP interaction: Tyr 1105 of p190, a substrate for c-Src, is the sole p-Tyr mediator of complex formation. Mol Cell Biol. 1998;18:7052-7063.
345. Lee CS, Choi CK, Shin EY, Schwartz MA, Kim EG. Myosin II directly binds and inhibits Dbl family guanine nucleotide exchange factors: a possible link to Rho family GTPases. J Cell Biol. 2010;190:663-674. doi: 10.1083/jcb.201003057.
346. Nusrat A, Giry M, Turner JR, Colgan SP, Parkos CA, Carnes D, Lemichez E, Boquet P, Madara JL. Rho protein regulates tight junctions and peri-junctional actin organization in polarized epithelia. Proc Natl Acad Sci U S A. 1995;92:10629-10633.
347. Terry SJ, Zihni C, Elbediwy A, Vitiello E, Leefa Chong San IV, Balda MS, Matter K. Spatially restricted activation of RhoA signalling at epithelial junctions by p114RhoGEF drives junction formation and morphogenesis. Nat Cell Biol. 2011;13:159-166. doi: 10.1038/ncb2156.
348. Richnau N, Aspenström P. Rich, a rho GTPase-activating protein domain-containing protein involved in signaling by Cdc42 and Rac1. J Biol Chem. 2001;276:35060-35070. doi: 10.1074/jbc.M103540200.
349. van Buul JD, Geerts D, Huveneers S. Rho GAPs and GEFs: controling switches in endothelial cell adhesion. Cell Adh Migr. 2014;8:108-124.
350. Hahn C, Schwartz MA. Mechanotransduction in vascular physiology and atherogenesis. Nat Rev Mol Cell Biol. 2009;10:53-62. doi: 10.1038/ nrm2596.
351. Kaunas R, Nguyen P, Usami S, Chien S. Cooperative effects of Rho and mechanical stretch on stress fber organization. Proc Natl Acad Sci U S A. 2005;102:15895-15900. doi: 10.1073/pnas.0506041102.
352. Goldyn AM, Rioja BA, Spatz JP, Ballestrem C, Kemkemer R. Force-induced cell polarisation is linked to RhoA-driven microtubule-inde-pendent focal-adhesion sliding. J Cell Sci. 2009;122:3644-3651. doi: 10.1242/jcs.054866.
353. Lee SK, Thomas GH. Rac1 modulation of the apical domain is negatively regulated by β (Heavy)-spectrin. Mech Dev. 2011;128:116-128. doi: 10.1016/j.mod.2010.11.004.
354. Liu KD, Datta A, Yu W, Brakeman PR, Jou TS, Matthay MA, Mostov KE. Rac1 is required for reorientation of polarity and lumen formation through a PI 3-kinase-dependent pathway. Am J Physiol Renal Physiol. 2007;293:F1633-F1640. doi: 10.1152/ajprenal.00053.2007.
355. Dipaolo BC, Davidovich N, Kazanietz MG, Margulies SS. Rac1 pathway mediates stretch response in pulmonary alveolar epithelial cells. Am J Physiol Lung Cell Mol Physiol. 2013;305:L141-L153. doi: 10.1152/ ajplung.00298.2012.
356. Abiko H, Fujiwara S, Ohashi K, Hiatari R, Mashiko T, Sakamoto N, Sato M, Mizuno K. Rho guanine nucleotide exchange factors involved in cyclic-stretch-induced reorientation of vascular endothelial cells. J Cell Sci. 2015;128:1683-1695. doi: 10.1242/jcs.157503.
357. Wojciak-Stothard B, Ridley AJ. Shear stress-induced endothelial cell polarization is mediated by Rho and Rac but not Cdc42 or PI 3-kinases. J Cell Biol. 2003;161:429-439. doi: 10.1083/jcb.200210135.
358. Tzima E, Del Pozo MA, Kiosses WB, Mohamed SA, Li S, Chien S, Schwartz MA. Activation of Rac1 by shear stress in endothelial cells mediates both cytoskeletal reorganization and effects on gene expression. EMBO J. 2002;21:6791-6800.
359. Birukova AA, Adyshev D, Gorshkov B, Bokoch GM, Birukov KG, Verin AD. GEF-H1 is involved in agonist-induced human pulmonary endothelial barrier dysfunction. Am J Physiol Lung Cell Mol Physiol. 2006;290:L540-L548. doi: 10.1152/ajplung.00259.2005.
360. Va n Rijssel J, Timmerman I, Va n Alphen FP, Hoogenboezem M, Korchynskyi O, Geerts D, Geissler J, Reedquist KA, Niessen HW, Van Buul JD. The Rho-GEF Trio regulates a novel pro-infammatory pathway through the transcription factor Ets2. Biol Open. 2013;2:569-579. doi: 10.1242/bio.20134382.
361. Mikelis CM, Simaan M, Ando K, Fukuhara S, Sakurai A, Amornphimoltham P, Masedunskas A, Weigert R, Chavakis T, Adams RH, Offermanns S, Mochizuki N, Zheng Y, Gutkind JS. RhoA and ROCK mediate histamine-induced vascular leakage and anaphylactic shock. Nat Commun. 2015;6:6725. doi: 10.1038/ncomms7725.
362. Sawada N, Itoh H, Miyashita K, Tsujimoto H, Sone M, Yamahara K, Arany ZP, Hofmann F, Nakao K. Cyclic GMP kinase and RhoA Ser188 phosphorylation integrate pro- and antifbrotic signals in blood vessels. Mol Cell Biol. 2009;29:6018-6032. doi: 10.1128/MCB.00225-09.
363. Kato M, Blanton R, Wang GR, Judson TJ, Abe Y, Myoishi M, Karas RH, Mendelsohn ME. Direct binding and regulation of RhoA protein by cyclic GMP-dependent protein kinase Iα. J Biol Chem. 2012;287:41342-41351. doi: 10.1074/jbc.M112.421040.
364. Ishizaki T, Maekawa M, Fujisawa K, Okawa K, Iwamatsu A, Fujita A, Watanabe N, Saito Y, Kakizuka A, Morii N, Narumiya S. The small GTP-binding protein Rho binds to and activates a 160 kDa Ser/Thr protein kinase homologous to myotonic dystrophy kinase. EMBO J. 1996;15:1885-1893.
365. Nakagawa O, Fujisawa K, Ishizaki T, Saito Y, Nakao K, Narumiya S. ROCK-I and ROCK-II, two isoforms of Rho-associated coiled-coil forming protein serine/threonine kinase in mice. FEBS Lett. 1996;392:189-193.
366. Shimizu Y, Thumkeo D, Keel J, Ishizaki T, Oshima H, Oshima M, Noda Y, Matsumura F, Taketo MM, Narumiya S. ROCK-I regulates closure of the eyelids and ventral body wall by inducing assembly of actomyosin bundles. J Cell Biol. 2005;168:941-953. doi: 10.1083/jcb.200411179.
367. Thumkeo D, Keel J, Ishizaki T, Hirose M, Nonomura K, Oshima H, Oshima M, Taketo MM, Narumiya S. Targeted disruption of the mouse rho-associated kinase 2 gene results in intrauterine growth retardation and fetal death. Mol Cell Biol. 2003;23:5043-5055.
368. Uehata M, Ishizaki T, Satoh H, Ono T, Kawahara T, Morishita T, Tamakawa H, Yamagami K, Inui J, Maekawa M, Narumiya S. Calcium sensitization of smooth muscle mediated by a Rho-associated protein ki-nase in hypertension. Nature. 1997;389:990-994. doi: 10.1038/40187.
369. Takami A, Iwakubo M, Okada Y, Kawata T, Odai H, Takahashi N, Shindo K, Kimura K, Tagami Y, Miyake M, Fukushima K, Inagaki M, Amano M, Kaibuchi K, Iijima H. Design and synthesis of Rho kinase inhibitors (I). Bioorg Med Chem. 2004;12:2115-2137. doi: 10.1016/j. bmc.2004.02.025.
370. Ikenoya M, Hidaka H, Hosoya T, Suzuki M, Yamamoto N, Sasaki Y. Inhibition of rho-kinase-induced myristoylated alanine-rich C ki-nase substrate (MARCKS) phosphorylation in human neuronal cells by H-1152, a novel and specifc Rho-kinase inhibitor. J Neurochem. 2002;81:9-16.
371. Jiang C, Huang H, Liu J, Wang Y, Lu Z, Xu Z. Fasudil, a Rho-kinase inhibitor, attenuates bleomycin-induced pulmonary fbrosis in mice. Int J Mol Sci. 2012;13:8293-8307. doi: 10.3390/ijms13078293.
372. Li Y, Wu Y, Wang Z, Zhang XH, Wu WK. Fasudil attenuates lipopoly-saccharide-induced acute lung injury in mice through the rho/rho kinase pathway. Med Sci Monit. 2010;16:BR112-118
373. Xiao JW, Zhu XY, Wang QG, Zhang DZ, Cui CS, Zhang P, Chen HY, Meng LL. Acute effects of Rho-kinase inhibitor fasudil on pulmonary arterial hypertension in patients with congenital heart defects. Circ J. 2015;79:1342-1348. doi: 10.1253/circj.CJ-14-1015.
374. Shibuya M, Suzuki Y, Sugita K, Saito I, Sasaki T, Takakura K, Nagata I, Kikuchi H, Takemae T, Hidaka H. Effect of AT877 on cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Results of a prospective placebo-controlled double-blind trial. J Neurosurg. 1992;76:571-577. doi: 10.3171/jns.1992.76.4.0571.
375. Shimokawa H, Hiramori K, Iinuma H, Hosoda S, Kishida H, Osada H, Katagiri T, Yamauchi K, Yui Y, Minamino T, Nakashima M, Kato K. Anti-anginal effect of fasudil, a Rho-kinase inhibitor, in patients with stable effort angina: a multicenter study. J Cardiovasc Pharmacol. 2002;40:751-761.
376. Somlyo AV, Bradshaw D, Ramos S, Murphy C, Myers CE, Somlyo A P. Rho-kinase inhibitor retards migration and in vivo dissemination of human prostate cancer cells. Biochem Biophys Res Commun. 2000;269:652-659. doi: 10.1006/bbrc.2000.2343.
377. Casey DB, Badejo AM, Dhaliwal JS, Sikora JL, Fokin A, Golwala NH, Greco AJ, Murthy SN, Nossaman BD, Hyman AL, Kadowitz PJ. Analysis of responses to the Rho-kinase inhibitor Y-27632 in the pulmonary and systemic vascular bed of the rat. Am J Physiol Heart Circ Physiol. 2010;299:H184-H192. doi: 10.1152/ajpheart.00181.2009.
378. Jacobson JR, Barnard JW, Grigoryev DN, Ma SF, Tuder RM, Garcia JG. Simvastatin attenuates vascular leak and infammation in mu-rine infammatory lung injury. Am J Physiol Lung Cell Mol Physiol. 2005;288:L1026-L1032. doi: 10.1152/ajplung.00354.2004.
379. Shyamsundar M, McKeown ST, O'Kane CM, Craig TR, Brown V, Thickett DR, Matthay MA, Taggart CC, Backman JT, Elborn JS, McAuley DF. Simvastatin decreases lipopolysaccharide-induced pulmonary infammation in healthy volunteers. Am J Respir Crit Care Med. 2009;179:1107-1114. doi: 10.1164/rccm.200810-1584OC.
380. Craig TR, Duffy MJ, Shyamsundar M, McDowell C, O'Kane CM, Elborn JS, McAuley DF. A randomized clinical trial of hydroxymeth-ylglutaryl- coenzyme a reductase inhibition for acute lung injury (The HARP Study). Am J Respir Crit Care Med. 2011;183:620-626. doi: 10.1164/rccm.201003-0423OC.
381. McAuley DF, Laffey JG, O'Kane CM, Perkins GD, Mullan B, Trinder TJ, Johnston P, Hopkins PA, Johnston AJ, McDowell C, McNally C; HARP-2 Investigators; Irish Critical Care Trials Group. Simvastatin in the acute respiratory distress syndrome. N Engl J Med. 2014;371:1695-1703. doi: 10.1056/NEJMoa1403285.
382. Garcia JG, Liu F, Verin AD, Birukova A, Dechert MA, Gerthoffer WT, Bamberg JR, English D. Sphingosine 1-phosphate promotes endothelial cell barrier integrity by Edg-dependent cytoskeletal rearrangement. J Clin Invest. 2001;108:689-701. doi: 10.1172/JCI12450.
383. Dudek SM, Jacobson JR, Chiang ET, Birukov KG, Wang P, Zhan X, Garcia JG. Pulmonary endothelial cell barrier enhancement by sphingo-sine 1-phosphate: roles for cortactin and myosin light chain kinase. J Biol Chem. 2004;279:24692-24700. doi: 10.1074/jbc.M313969200.
384. Chavez A, Schmidt TT, Yazbeck P, Rajput C, Desai B, Sukriti S, Giantsos-Adams K, Knezevic N, Malik AB, Mehta D. S1PR1 Tyr143 phosphorylation downregulates endothelial cell surface S1PR1 expression and responsiveness. J Cell Sci. 2015;128:878-887. doi: 10.1242/ jcs.154476.
385. 1-degradative mechanisms leads to vascular leak in mice. J Clin Invest. 2011;121:2290-2300. doi: 10.1172/ JCI45403.
386. Dudek SM, Camp SM, Chiang ET, Singleton PA, Usatyuk PV, Zhao Y, Natarajan V, Garcia JG. Pulmonary endothelial cell barrier enhancement by FTY720 does not require the S1P1 receptor. Cell Signal. 2007;19:1754-1764. doi: 10.1016/j.cellsig.2007.03.011.
387. Peng X, Hassoun PM, Sammani S, McVerry BJ, Burne MJ, Rabb H, Pearse D, Tuder RM, Garcia JG. Protective effects of sphingosine 1-phosphate in murine endotoxin-induced infammatory lung injury. Am J Respir Crit Care Med. 2004;169:1245-1251. doi: 10.1164/ rccm.200309-1258OC.
388. Sanchez T, Estrada-Hernandez T, Paik JH, Wu MT, Venkataraman K, Brinkmann V, Claffey K, Hla T. Phosphorylation and action of the im-munomodulator FTY720 inhibits vascular endothelial cell growth factor-induced vascular permeability. J Biol Chem. 2003;278:47281-47290. doi: 10.1074/jbc.M306896200.
389. Oo ML, Thangada S, Wu MT, Liu CH, Macdonald TL, Lynch KR, Lin CY, Hla T. Immunosuppressive and anti-angiogenic sphingosine 1-phosphate receptor-1 agonists induce ubiquitinylation and proteasomal degradation of the receptor. J Biol Chem. 2007;282:9082-9089. doi: 10.1074/jbc.M610318200.
390. Camp SM, Chiang ET, Sun C, Usatyuk PV, Bittman R, Natarajan V, Garcia JG, Dudek SM. Pulmonary endothelial cell barrier enhancement by novel FTY720 analogs: methoxy-FTY720, fuoro-FTY720, and β-glucuronide-FTY720. Chem Phys Lipids. 2015;191:16-24. doi: 10.1016/j.chemphyslip.2015.08.004.
391. Sun X, Ma SF, Wade MS, et al. Functional promoter variants in sphingo-sine 1-phosphate receptor 3 associate with susceptibility to sepsis-associated acute respiratory distress syndrome. Am J Physiol Lung Cell Mol Physiol. 2013;305:L467-L477. doi: 10.1152/ajplung.00010.2013.
392. Sun X, Singleton PA, Letsiou E, et al. Sphingosine-1-phosphate recep-tor-3 is a novel biomarker in acute lung injury. Am J Respir Cell Mol Biol. 2012;47:628-636. doi: 10.1165/rcmb.2012-0048OC.
393. Gale NW, Thurston G, Hackett SF, Renard R, Wang Q, McClain J, Martin C, Witte C, Witte MH, Jackson D, Suri C, Campochiaro PA, Wiegand SJ, Yancopoulos GD. Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by Angiopoietin-1. Dev Cell. 2002;3:411-423.
394. Bhandari V, Choo-Wing R, Lee CG, Zhu Z, Nedrelow JH, Chupp GL, Zhang X, Matthay MA, Ware LB, Homer RJ, Lee PJ, Geick A, de Fougerolles AR, Elias JA. Hyperoxia causes angiopoietin 2-mediated acute lung injury and necrotic cell death. Nat Med. 2006;12:1286-1293. doi: 10.1038/nm1494.
395. Roviezzo F, Tsigkos S, Kotanidou A, Bucci M, Brancaleone V, Cirino G, Papapetropoulos A. Angiopoietin-2 causes infammation in vivo by promoting vascular leakage. J Pharmacol Exp Ther. 2005;314:738-744. doi: 10.1124/jpet.105.086553.
396. Mammoto T, Jiang A, Jiang E, Mammoto A. Platelet rich plasma extract promotes angiogenesis through the angiopoietin1-Tie2 pathway. Microvasc Res. 2013;89:15-24. doi: 10.1016/j.mvr.2013.04.008.
397. Parikh SM, Mammoto T, Schultz A, Yuan HT, Christiani D, Karumanchi SA, Sukhatme VP. Excess circulating angiopoietin-2 may contribute to pulmonary vascular leak in sepsis in humans. PLoS Med. 2006;3:e46. doi: 10.1371/journal.pmed.0030046.
398. Orfanos SE, Kotanidou A, Glynos C, Athanasiou C, Tsigkos S, Dimopoulou I, Sotiropoulou C, Zakynthinos S, Armaganidis A, Papapetropoulos A, Roussos C. Angiopoietin-2 is increased in severe sepsis: correlation with infammatory mediators. Crit Care Med. 2007;35:199-206. doi: 10.1097/01.CCM.0000251640.77679.D7.
399. Wada T, Jesmin S, Gando S, Yanagida Y, Mizugaki A, Sultana SN, Zaedi S, Yokota H. The role of angiogenic factors and their soluble receptors in acute lung injury (ALI)/ acute respiratory distress syndrome (ARDS) associated with critical illness. J Infamm (Lond). 2013;10:6. doi: 10.1186/1476-9255-10-6.
400. Diamond JM, Porteous MK, Cantu E, et al; Lung Transplant Outcomes Group. Elevated plasma angiopoietin-2 levels and primary graft dysfunction after lung transplantation. PLoS One. 2012;7:e51932. doi: 10.1371/ journal.pone.0051932.
401. Meyer NJ, Li M, Feng R, et al. ANGPT2 genetic variant is associated with trauma-associated acute lung injury and altered plasma angiopoi-etin-2 isoform ratio. Am J Respir Crit Care Med. 2011;183:1344-1353. doi: 10.1164/rccm.201005-0701OC.
402. Thurston G, Rudge JS, Ioffe E, Zhou H, Ross L, Croll SD, Glazer N, Holash J, McDonald DM, Yancopoulos GD. Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat Med. 2000;6:460-463. doi: 10.1038/74725.
403. Chu D, Sullivan CC, Du L, Cho AJ, Kido M, Wolf PL, Weitzman MD, Jamieson SW, Thistlethwaite PA. A new animal model for pulmonary hypertension based on the overexpression of a single gene, angiopoi-etin-1. Ann Thorac Surg. 2004;77:449-56; discussion 456. doi: 10.1016/ S0003-4975(03)01350-X.
404. Sullivan CC, Du L, Chu D, Cho AJ, Kido M, Wolf PL, Jamieson SW, Thistlethwaite PA. Induction of pulmonary hypertension by an an-giopoietin 1/TIE2/serotonin pathway. Proc Natl Acad Sci U S A. 2003;100:12331-12336. doi: 10.1073/pnas.1933740100.
405. Thistlethwaite PA, Lee SH, Du LL, Wolf PL, Sullivan C, Pradhan S, Deutsch R, Jamieson SW. Human angiopoietin gene expression is a marker for severity of pulmonary hypertension in patients undergoing pulmonary thromboendarterectomy. J Thorac Cardiovasc Surg. 2001;122:65-73. doi: 10.1067/mtc.2001.113753.
406. Young JA, Ting KK, Li J, et al. Regulation of vascular leak and recovery from ischemic injury by general and VE-cadherin-restricted miRNA antagonists of miR-27. Blood. 2013;122:2911-2919. doi: 10.1182/ blood-2012-12-473017.
407. Yan B, Yao J, Liu JY, Li XM, Wang XQ, Li YJ, Tao ZF, Song YC, Chen Q, Jiang Q. lncRNA-MIAT regulates microvascular dysfunction by functioning as a competing endogenous RNA. Circ Res. 2015;116:1143-1156. doi: 10.1161/CIRCRESAHA.116.305510.
408. Roderburg C, Luedde M, Vargas Cardenas D, Vucur M, Scholten D, Frey N, Koch A, Trautwein C, Tacke F, Luedde T. Circulating microRNA-150 serum levels predict survival in patients with critical illness and sepsis. PLoS One. 2013;8:e54612. doi: 10.1371/journal.pone.0054612.
409. Rajput C, Tauseef M, Farazuddin M, Yazbeck P, Amin MR, Avin Br V, Sharma T, Mehta D. MicroRNA-150 Suppression of Angiopoetin-2 Generation and Signaling Is Crucial for Resolving Vascular Injury. Arterioscler Thromb Vasc Biol. 2016;36:380-388. doi: 10.1161/ ATVBAHA.115.306997.
410. Wary KK, Vogel SM, Garrean S, Zhao YD, Malik AB. Requirement of al-pha(4)beta(1) and alpha(5)beta(1) integrin expression in bone-marrow-derived progenitor cells in preventing endotoxin-induced lung vascular injury and edema in mice. Stem Cells. 2009;27:3112-3120. doi: 10.1002/stem.241.
411. Jones CP, Pitchford SC, Lloyd CM, Rankin SM. CXCR2 mediates the recruitment of endothelial progenitor cells during allergic airways remodeling. Stem Cells. 2009;27:3074-3081. doi: 10.1002/stem.222.
412. Li JW, Wu X. Mesenchymal stem cells ameliorate LPS-induced acute lung injury through KGF promoting alveolar fuid clearance of alveolar type II cells. Eur Rev Med Pharmacol Sci. 2015;19:2368-2378.
413. Theise ND, Henegariu O, Grove J, Jagirdar J, Kao PN, Crawford JM, Badve S, Saxena R, Krause DS. Radiation pneumonitis in mice: a severe injury model for pneumocyte engraftment from bone marrow. Exp Hematol. 2002;30:1333-1338.
414. Urbich C, Aicher A, Heeschen C, Dernbach E, Hofmann WK, Zeiher AM, Dimmeler S. Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells. J Mol Cell Cardiol. 2005;39:733-742. doi: 10.1016/j.yjmcc.2005.07.003.
415. Vicente-Manzanares M, Ma X, Adelstein RS, Horwitz AR. Non-muscle myosin II takes centre stage in cell adhesion and migration. Nat Rev Mol Cell Biol. 2009;10:778-790. doi: 10.1038/nrm2786.
416. Etienne-Manneville S, Hall A. Rho GTPases in cell biology. Nature. 2002;420:629-635. doi: 10.1038/nature01148.